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ABSTRACT 
The genotoxic -effects of a. number of 'hhemical agents have been 
shown to cause clastooenicitv, terafojafenicity, mutagenicity, and 
carcinogenicity at different dosage.;©f-administration in various test systems. 
Although steroids have been used widely as contraceptives, antiallergics, anti-
inflammatory and antidepressant agents therapeutically, steroids have been 
reported to cause chromosome breakage and induce sister chromatid 
exchanges in humans and animals, both in vitro and in vivo. Amelioration of 
the genotoxic damage caused by steroids must be attempted, preferably 
through the use of dietary antimutagens, to help the patients while taking 
steroid therapy or after. 
The amelioration of genotoxicity has been attempted mostly through 
the use of known antioxidants and chemical extracts from plant sources which 
have wider medical application. Although some studies have been carried out 
on the antigenotoxic potential of natural plant products, many more 
antioxidants and chemical extracts from plants need to be studied in order to 
assess their antigenotoxic potential against different kinds of steroids. Hence, 
the present study is directed towards the investigation of the antigenotoxic 
role of selected well-known antioxidants in the case of androgenic steroids, 
which induce genotoxicity in human lymphocytes in vitro. 
The present work aims to study the effects of androgenic anabolic 
steroids on cultured human chromosomes and to observe changes in the 
level of genotoxicity with the administration of antioxidants in vitro. 
Androgenic anabolic steroids such as Stanozolol, Trenbolone, 
Norethandrolone, Oxandrolone and Testosterone propionate were used at 
different toxic concentrations for induction of genotoxicity in human peripheral 
blood lymphocyte culture, using chromosomal aberrations (CAs) and sister 
chromatid exchanges (SCEs) as parameters, with and without metabolic 
activation system. Appropriate positive and negative controls were used in all 
experiments. Gingerol, genistein, epicatechin gallate (ECG), and 
epigallocatechin gallate (EGCG) were used as antimutagenic principles for 
reducing the genotoxicity caused by steroids. 
The androgenic anabolic steroids are widely used in the treatment of 
many disorders such as anemia, hereditary angioedema, hormonal diseases, 
for promoting muscle regrowth in patients, athletes and bodybuilders use 
them for performance enhancement, and also they are used by veterinarians 
on livestock as a promoter of grov/th in animal husbandry. There is sufficient 
data to indicate that the prolonged use of androgenic steroids can cause 
cancer among animals and humans. The androgenic anabolic steroids 
studied here for their potential genotoxic effects and also the antioxidants 
used to ameliorate the genotoxic effects of these steroids on chromosomes 
are given below. 
Stanozolol, a synthetic steroid, is widely used as a treatment for many 
disorders such as anemia and hereditary angioedema, and also used by 
athletes and bodybuilders for performance enhancement. There is sufficient 
evidence for the carcinogenicity of Stanozolol in humans. Stanozolol was 
further studied for its genotoxic effect on human lymphocyte chromosomes 
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using CAs and SCEs, in the presence as well as the absence of metabolic 
activation, with and without NADP, as the reports link prostate and liver 
cancers to high steroid dosage and long term steroid abuse. Stanozolol was 
studied at different concentrations (1, 10, 20, 40 and 60 |aM) and was found to 
be almost equally genotoxic, with and without metabolic activation (S9 mix). 
Epigallocatechin gallate (EGCG), an antioxidant principle, found in tea has 
antigenotoxic and free radical scavenging property, and it was administered at 
20 and 30 jiM with 40 and 60 \xM of Stanozolol. This treatment leads to 
reduction of CAs and SCEs. The results point to a protective role of EGCG 
against Stanozolol-induced genotoxicity. 
Trenbolone is also a synthetic steroid used frequently by veterinarians 
on livestock as a promoter of growth, and it is well-known that the 
bodybuilders use the drug illegally to increase body mass and strength. It was 
studied in human lymphocytes using CAs and SCEs, both in the presence 
and in the absence of metabolic activation, with and without NADP. 
Trenbolone was studied at different concentrations (1, 10, 20, 40 and 60 iiM) 
and was found to be genotoxic in the presence as well as absence of S9 mix. 
EGCG was administered at 20 and 30 |aM with 40 and 60 |aM of Trenbolone 
leading to significant reduction of CAs and SCEs, suggesting a protective role 
of EGCG against Trenbolone-induced genotoxic damage. The antigenotoxic 
effect of EGCG was clearly dose-dependent. The highest protective effect 
was observed at 30 jiM of EGCG. 
Norethandrolone, an oral anabolic androgenic steroid (AAS), is used 
in bodybuilding and in the treatment of hormonal diseases. The genotoxicity of 
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norethandrolone was studied in human lymphocytes using CAs and SCEs as 
parameters. Norethandrolone was found to be genotoxic at 30 and 40 iiM of 
concentration. Genistein is an anticarcinogenic polyphenol found in soybean 
and has antioxidant properties. Gingerol, a key constituent of the plant ginger 
{Zingiber officinale), also shows antioxidant activities. The effect of genistein 
and gingerol was studied against norethandrolone-induced genotoxic damage 
using CAs and SCEs. Genistein and gingerol were administered separately 
with norethandrolone. Genistein was used at 30 and 40 |LIM along with 30 and 
40 \xM of norethandrolone. Gingerol was administered at 20 and 30 |iM along 
with 30 and 40 \JLM of norethandrolone. These treatments result in a 
substantial reduction of CAs and SCEs, suggesting a protective role of 
genistein and gingerol against norethandrolone-induced genotoxicity. 
Similarly, another oral anabolic androgenic steroid, Oxandrolone, was 
studied for its genotoxic effect on human lymphocytes taking CAs and SCEs 
as parameters of genotoxic damage and the compound was found to be 
genotoxic at 30 and 40 |aM. Genistein and gingerol were administered at the 
same dosage as in the case of norethandrolone. A similar result was obtained 
where there was reduction in CAs and SCEs, implying an antigenotoxic action 
of the antioxidants used. 
Testosterone propionate (TP), a very strong androgenic compound 
having a high anabolic effect, was studied at different concentrations (10, 20 
and 40 |iM) using CAs and SCEs as parameters in human lymphocytes in 
vitro, and it was observed that TP shows significant genotoxicity at 20 and 40 
l^ M in the presence of metabolic activation system, but it is not genotoxic at 
any of the concentrations in the absence of metabolic activation. Epicatechin 
gallate (ECG), an antioxidant found in tea, having properties similar to EGCG, 
was used in the case of TP as an antimutagenic agent. ECG was 
administered at 20, 30 and 40 ^M along with TP at 20 and 40 \xM in the 
presence of S9 mix. ECG substantially reduced CAs and SCEs induced by TP 
in the presence of S9 mix. This action of ECG points to the fact that it has 
strong antigenotoxic potential. 
The antigenotoxic potential of genistein and gingerol was also studied 
against anticancer drugs such as Methylmethanesulphonate (MMS) and 
Cyclophosphamide (CP) which are known mutagens. MMS was used at 60 
|iM genotoxic concentration for inducing CAs and SCEs in human 
lymphocytes, with and without S9 mix, along with 5, 10 and 20 ^M of 
gingerol. Gingerol reduced CAs and SCEs both in the presence and absence 
of S9 mix, but was more effective in reducing genotoxicity in the presence of 
metabolic activation. Gingerol was not genotoxic in itself. Genistein, at 25 
and 40 i^ M, was used against MMS at 60 \xM in the absence of S9 mix, and 
against CP at 0.16 |ig/ml in the presence of S9 mix. Genistein proved to be 
equally effective in reducing CAs in the absence as well as presence of 
metabolic activation, but in the case of SCEs genistein proved more effective 
in the absence of S9 mix (MMS). EGCG was also studied against MMS 
(without S9 mix) and CP (with S9 mix) in human lymphocyte chromosomes. 
EGCG was administered at 10, 20 and 30 |aM along with MMS at 60 i^ M and 
CP at 0.16 |ig/ml separately, and proved to be slightly more effective in 
reducing CAs and SCEs in the case of CP. 
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The results of the present study divulge that the genotoxicity of 
androgenic anabolic steroids can be ameliorated by the use of antioxidants. 
Some of the androgenic steroids studied here such as TP, require metabolic 
activation in order to exhibit genotoxic effects, while others like 
Norethandrolone and Oxandrolone do not require metabolic activation. Still 
others like Stanozolol and Trenbolone are genotoxic in the presence as v\/ell 
as absence of S9 mix. The scavenging effect of O^  and OH' may, in fact, 
contribute toward explaining the pharmacological action of gingerol and 
determining the antitumor promotional activity of gingerol, the major pungent 
principle of ginger. Both neoplastic and mutagenic properties have been 
observed in MMS which is a monofunctional alkylating agent. It alkylates DNA 
at the N-7 position of guanine and the N-3 position of adenine. CP is also an 
alkylating agent and after metabolic activation, it produces active mutagenic 
metabolic product phospharamide mustard. Genistein may behave as free 
radical scavenger and hence, might react with metabolites which are 
carcinogenic before they are able to inflict DNA damaging effects. Genistein is 
particularly effective in quenching free radicals produced by toxic agents and 
protects cells against oxidative damage especially with respect to DNA. The 
results of the present study reveal that the selected dosages of genistein and 
gingerol are not genotoxic per se but reduce the genotoxic damage caused by 
oxandrolone and norethandrolone in human lymphocytes in vitro. Stanozolol 
and Trenbolone, have the potential to cause genotoxic damage in human 
lymphocytes in vitro at higher dosage both in the presence and absence of S9 
mix. There is very little information available on the exact reasons for the 
genotoxic behavior of stanozolol and trenbolone. However, the present study 
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is concurrent with the studies performed on synthetic steroids such as 
cyproterone acetate, ethynodiol diacetate, chlormadinone acetate, 
medroxyprogesterone acetate, norgestrel and megestrol acetate that induced 
CAs and SCEs with or without metabolic activation system. TP is genotoxic 
only in the presence of metabolic activation (S9 mix + NADP). The first step 
may involve aromatic hydroxylation catalyzed by cytochrome p450 as in the 
case of other steroids. Cytochrome p450 in liver S9 fractions plays an 
important role in activating promutagens to proximate and/or ultimate 
mutagens. ECG reduces genotoxicity of TP in human lymphocytes and the 
reduction in genotoxic damage may be due to the possibility of the prevention 
of metabolic activation of TP by ECG. 
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INTRODUCTION 
The androgenic anabolic steroids that occur naturally are synthesized 
in the testis, ovary and adrenal gland from cholesterol via pregnenolone and 
bind to receptors that are specifically occurring in reproductive tissues, 
muscles and fat bodies (Mooradian et a!., 1987). Synthetic anabolic steroids 
are mainly related to the principal male hormone testosterone (Haynes and 
Murad, 1985). Below is a brief description of the androgenic anabolic steroids 
studied for their potential genotoxic effects and the natural plant products 
(antioxidants) used to ameliorate their genotoxic effects on chromosomes. 
Androgenic Anabolic Steroids 
(i) Stanozolol 
Stanozolol is a synthetic steroid similar to the naturally occurring 
androgen called testosterone. It is used in the treatment of many disorders 
such as anemia and hereditary angioedema (Gannon, 1994). Athletes and 
bodybuilders commonly use this anabolic steroid for performance 
enhancement (Elashoff eta!., 1991). 
R 
Its large oral bioavailability is due to a CI7 alpha-alkylation principle 
which allows the hormone to survive the first pass through liver metabolism. 
At high dosage, Stanozolol could exert a proliferative effect on liver cells 
(Boada et al., 1999). Precocious prostate cancer has been reported after a 
long term steroid abuse (Roberts and Essenhigh, 1986). Hepatic cancer has 
also been linked to anabolic steroidal abuse (Overly et al., 1984). 
Due to reports linking prostate and liver cancers to high steroid dosage 
and long term steroid abuse, stanozolol was studied for its genotoxic effect on 
human lymphocyte chromosomes using chromosomal aberrations and sister 
chromatid exchanges, both in the presence and absence of metabolic 
activation, and with and without NADP. 
(ii) Trenbolone 
This is also a synthetic steroid used frequently by veterinarians on 
livestock as a promoter of growth in animal husbandry (Richold, 1988). 
Trenbolone compounds have not yet been approved by the Food and Drug 
Administration, USA for use by humans due to their considerable negative 
side effects, although bodybuilders use the drug illegally to increase body 
mass and strength. Cases of prostate and hepatic cancers have been 
associated with long term anabolic steroid abuse (Roberts and Essenhigh, 
1986; Overly et al., 1984). Trenbolone compounds increase nitrogen uptake 
by muscles after metabolization, leading to increased rate of protein synthesis 
(http://en.wikipedia.org/wiki/trenbolone, 2007). 
Prostate and hepatic cancers associated with anabolic steroid abuse 
has led to the study of Trenbolone at different doses for genotoxicity in 
cultured human lymphocytes using chromosomal aberrations and sister 
chromatid exchanges as parameters, in the presence as well as absence of 
metabolic activation system, with and without NADP. 
(iii) Norethandrolone 
This is an oral anabolic androgenic steroid (AAS) synthesized and 
approved under the brand name of Nilevar and used in bodybuilding. It is 
used in the treatment of hormonal diseases for promoting muscle regrowth in 
patients. It has moderate progestagenic activity and shows liver toxicity as a 
17-alkyiated steroid (IPCS, 1993). 
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The International Agency on Cancer (lAC), on the basis of 
epidemiological studies, classifies androgenic anabolic steroids mainly as 
probably carcinogenic (Group 2A) (Martelli et a!., 2003). Hepatic and prostate 
cancers have been reported after long term steroidal abuse (Roberts and 
Essenhigh, 1986; Overly et al., 1984). Keeping in view the above reports, 
Norethandrolone was studied for its genotoxicity using chromosomal 
aberrations and sister chromatid exchanges as parameters in human 
lymphocytes in vitro. 
(iv) Oxandrolone 
It is also an oral anabolic androgenic steroid, synthesized, approved 
and sold as Anavar and used in bodybuilding (IPCS, 1993). It has moderate 
progestogenic activity and shares liver toxicity issues common to 17-alkylated 
steroids. It is used in the treatment of anemia and hereditary angioedema 
(Gannon, 1994) and also prescribed for promoting muscle regrowth in the 
patients suffering from Involuntary weight loss in treating osteoporosis. 
Cases of hepatic and precocious prostate cancers have been linked to long 
term AS abuse (Roberts and Essenhigh, 1986; Overly et al., 1984). Such 
reports linking cancers to AAS abuse has led to our study of oxandrolone for 
Its genotoxic effect on cultured human lymphocytes, applying the 
chromosomal aberrations and sister chromatid exchanges as parameters. 
(v) Testosterone propionate 
It is a very strong and androgenic compound having a high anabolic 
effect. Its users gain strength rapidly without increase in the body weight. 
Precocious prostate cancer and liver cancer have been associated with long 
term anabolic steroid abuse (Roberts and Essenhigh, 1986; Overly et al., 
1984). It is used for treating hormonal diseases, for boosting muscle regrowth 
in the patients, as also in bodybuilding (IPCS, 1993). 
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The drug TP has been shown to induce cell transformation in Syrian 
Hamster Embryo (SHE) cells (Tsutsul et a!., 1995). The TP treatment for a 
long duration leads to biomyoisarcomas in the vas deferens or uterus of 
Golden Syrian Hamsters (Hudson et al., 1998). This drug has an enhancing 
effect on phalloidin-induced liver toxicity in mice (Muraoka et al., 1988). TP 
also has a direct toxic effect in treating cell cultures neonatally in rat (Welder 
et al., 1995). Such reports of TP toxicity has led to the study of its genotoxic 
potential using cultured human lymphocytes in the presence as well as 
absence of metabolic activation system, with or without NADP, applying CAs 
and SCEs as parameters. 
Other similar estrogens and synthetic progestins among steroids have 
been reported to be genotoxic in human lymphocytes in vitro and in mouse 
bone marrow cells (Dhillon et al., 1994; Hundal et al., 1997; Joosten et al., 
2004; Siddique and Afzal, 2004a,b,c,d; Siddique and Afzal, 2005a; Siddique 
et al., 2005a,b; Siddique et al. 2006a). 
The genotoxic effect of steroids can be ameliorated by the use of 
antioxidants and natural plant products (Ahmad et al., 2004; Siddique and 
Afzal, 2005b; Siddique et al., 2005b; Siddique et al., 2006b; Siddique et al., 
2007 a,b,c; Beg et al., 2007; Siddique et al., 2008a,b). 
Natural Plant Products 
(I) Gingerol 
It is a key constituent of the plant ginger {Zingiber officinale) and is 
chiefly responsible for the pungency of ginger (Hasenohrl et al., 1998). It 
shows antioxidant activities through scavenging of superoxide and hydroxyl 
radicals and by inhibiting lipid peroxidation (Kikuzaki and Nakatani, 1993). 
The compound 6-gingerol is the major pharmacologically active component 
inducing apoptosis in cancer cells (Lee and Surh, 1998; Lee et al., 1998). 
OCH' 
Gingerol was studied for its antioxidant activity in different cases of 
genotoxicity induced by methylmethanesulphonate (MMS), norethandrolone 
and oxandrolone, in cultured human lymphocytes in the presence as well as 
absence of metabolic activation system (S9 mix) on frequencies of CAs and 
SCEs. 
(ii) Genistein 
It is an anticarcinogenic polyphenol found in soybean seeds as 
glycosides. It has antioxidant properties and is involved in modulation of cell 
proliferation and transformation (Muster et al., 1997). It is effective in 
quenching free radicals produced by toxic agents and protects cells against 
oxidative damage especially with respect to DNA (Foti et al., 2005; Lee et al., 
2000). 
Epidemiological and animal model studies have shown a link between 
a soy-rich diet and reduced incidence of breast and prostate cancers (Dixon 
and Ferreira, 2002). Several studies have suggested that genistein has a 
protective effect against lipid peroxidation of low and high density lipoproteins 
(Patel et a!., 2001; Ferretti et a!., 2004). In the present case, the antigenotoxic 
effect of geinstein was studied on the frequency of CAs and SCEs induced by 
MMS (in the absence of metabolic activation) and cyclophosphamide (in the 
presence of metabolic activation) in human lymphocytes in vitro. 
(iii) Epicatechin gailate (ECG) 
It is a catechin and polyphenolic antioxidant plant metabolite found in 
abundance in green, black, and oolong tea, derived from the tea plant 
Camellia sinensis (Balentine et al., 1998). Catechins have been studied for 
their health benefits in humans as well as the animals. 
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Reduction in atherosclerotic plaques (Chyu et al., 2004) and in 
carcinogenesis was seen in vitro (Mittal et al., 2004) and also in vivo. ECG 
was studied for its antioxidant effect on the CAs and SCEs induced by TP, 
both in the presence and absence of metabolic activation system in human 
lymphocytes in vitro. 
(iv) Epigallocatechin-3-gallate (EGCG) 
Epigallocatechin-3-gallate (EGCG), a compound closely related to 
ECG, is also a catechin and polyphenolic antioxidant plant metabolite found in 
abundance in various types of tea, derived from the tea plant Camellia 
sinensis (Balentine et al., 1998). 
OH 
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it helps protect the skin from ultraviolet radiation-induced genotoxic 
damage and tumor formation (Katiyar et al., 2007). EGCG was studied for its 
antimutagenic effect on the CAs and SCEs induced first by MMS and CP and 
then, in the next experiment, by Stanozolol and Trenbolone, both in the 
presence and absence of metabolic activation system in human lymphocytes 
in vitro. 
REVIEW OF LITERATURE 
Introduction to Steroids: Steroid hormones are the members of lipid 
compounds. They are mainly secreted by adrenal cortex of mammals, testis in 
male, ovary in the female and the placenta of mammals. Steroids consist of a 
tetracyclic nucleus, which is named cyclopentanoperhydrophenanthrene as 
shown in the figure below. 
Steroid nucleus 
The phenanthrene portion of the nucleus is comprised of rings A, B, and C, 
while D is the cyclopentane portion. Steroid hormones are responsible for a 
number of physiological and pharmacological effects in humans and other 
mammals. There are four basic classes of steroid hormones (Gorbman et al., 
1983): 
(A) Adenocorticoids 
(B) Estrogens 
(C) Progestins 
(D) Androgens 
(A) Adenocorticoids: Adrenocorticoids are grouped into 
(i) Glucocorticoids: Cortisol, corticosterone, and cortisone. They 
facilitate the formation of carbohydrates from non-carbohydrate 
sources (gluconeogenesis). 
(ii) Mineralocorticoids: They have ability to affect water and electrolyte 
metabolism (favoring retention of Na* and excretion of K*), e.g. 
Aldosterone 
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(B) Estrogens: Estrogens have the ability (secreted by the ovarian follicle) to 
stimulate female secondary sex characteristics and to help maintain the 
female reproductive tract e.g. estrone, estradiol and estriol. 
(C) Progestins: They stimulate the uterus and maintain uterine development 
during pregnancy (secreted by the corpus luteum of the ovary) eg. 
Progesterone, 17a-hydroxyprogesterone. 
(D) Androgens: They stimulate male characteristics and maintain male sex 
accessory glands and ducts (secreted by testis), e.g. Testosterone, 5 a-
dihydrotestosterone and androstenedione. The usefulness of above 
classification scheme is limited to some mammalian species, because 
glucocorticoids stimulates aspects of female reproduction in bony fishes. 
Aldosterone is usually classified as a mineralocorticoid, but it is a potent 
glucocorticoid in some animals. 
Structure and Nomenclature of Steroids: The basic nucleus of steroids has 
seventeen carbon atoms as shown in the figure below. 
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The nucleus has six asymmetric carbon atoms, shown with asterisk in the 
figure above. The nucleus is a flat structure lying in the plane of the page. If 
the hydrogen projects towards the observer, it is said to be in the cis or p 
position (solid line) and if the hydrogen projects away from the observer, it is 
said to be in the trans or a-position (broken lines) as shown in the figures 
below. 
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Additional carbons can be attached to tlie 17-carbon nucleus to form other 
classes of steroid compounds. If a methyl atom is attached to carbon 13, a 
new compound known as estrone (C-18) is formed. If a second methyl group 
is added to carbon 10, androstane (C-19) is formed. 
Metabolism of Steroids: Ovary, testis, adrenal gland and placenta have the 
ability to produce steroidal hormones, which is favoured by the trophic 
hormones such as andrenocorticotrophic hormone (ACTH), Luetinizing 
hormone (LH), Follicle stimulating hormone (FSH) and progesterone releasing 
hormone (PRL) and its receptor in the target tissues. It is also possible that 
one steroid secreting organ can take up steroid originally secreted by another 
organ and modify its activity. For example, mammalian adrenal cortex can 
take up progesterone secreted by the ovary and modifies it into corticoids. 
Chemical modifications may also occur in the brain, skin, salivary glands and 
other tissues. Steroid hormones are synthesized from a C27 precursor steroid, 
cholesterol. There are multiple sources of this steroid hormone precursor: de 
novo synthesis within the endocrine organ, and uptake from the circulating 
pool that is maintained by the liver or supplied in the diet. In blood, cholesterol 
circulates in the form of cholesterol esters bound to low and high density 
lipoprotein (LDL and HDL). For the synthesis of the steroid hormone, the 
breaking off of the six carbon side chain of the cholesterol occurs in 
mitochondria (Gorbman et al., 1983). 
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Dehydroepiandrosterone 
Cholesterol 17a-hydroxypregnenolone 
Dihydroxycholesterol • Pregnenolone Testosterone 
Progesterone 17a-hydroxy Androstenedione 
progesterone 
Deoxycorticosterone Deoxycortisol 
Aldosterone Corticosterone Cortisol 
t 
Estrone 
Androsterone 
Estradiol-17p 
Dehydrcorticosterone Cortisone 
Biogenesis of steroid hormones 
The inner membrane of the mitochondria contains an oxygenase 
known as cytochrome P450 which breaks the side chain of the cholesterol 
and this result into the formation of pregnenolone (C21). Pregnenolone is 
further transported to endoplasmic reticulum, where it is either oxidized to 
form progesterone or hydroxylated to form 17-hydroxypregnenolone. Further 
with the help of hydroxylating enzyme, desmolase and various cofactors 
triphosphopyridine nucleotide (TPNH) and molecular oxygen give rise to 
various steroid hormones as shown in the figure above. The catabolism of 
steroid occurs in both steroidogenic and peripheral tissues. The major site of 
catabolism is the liver, although the kidney and other tissues may catabolize 
circulating steroids to some extent. The major catabolic enzymes are involved 
in reductive reactions, particularly in the ring A and carbons 3 and 20. They 
are reduced to more water soluble and in active steroid sulfates and 
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glucoronides that are eliminated througli tlie urine or through the bile fluid, 
with ultimate excretion in the faeces (Gorbman et al., 1983). 
ANDROGENS 
The synthetic anabolic steroids are mainly related to the principal male 
hormone testosterone (Haynes and Murad, 1985). The androgenic anabolic 
steroids that occur naturally are synthesized in the testis, ovary and adrenal 
gland from cholesterol via pregnenolone and bind to receptors that are 
specifically occurring in reproductive tissues, muscles and fat bodies 
(Mooradian et al., 1987). The International Agency on Cancer (lAC), on the 
basis of epidemiological studies, classifies androgenic anabolic steroids 
mainly as probably carcinogenic (Group 2A) (Martelli et al., 2003). Given 
below is a brief review of some androgenic anabolic steroids studied for their 
potential cancerous and genotoxic effects and also some natural plant 
products (antioxidants) which are used to ameliorate the cancerous and 
genotoxic effects of androgenic anabolic steroids on chromosomes. 
Norethandrolone: 
Synonynns: 17 ENT; Ethylnortestosterone; Noretandrolone. 
Brand/Trade names: Nilevar, Norlutin, Laphal. 
Cancer/Genotoxicity Studies: Liver and prostate cancers have been 
reported after long term steroidal abuse (Roberts and Essenhigh, 1986; 
Overly et al., 1984). Norethandrolone has moderate progestogenic activity 
and shows liver toxicity as a 17-alkylated steroid (IPCS, 1993). Cholestatic 
jaundice has been observed after prolonged administration of 
norethandrolone (Claisse and Dalayeun, 1962; Cachin et al., 1962; Gordon, 
1960). Endometrial sarcomas of the uterus and carcinosarcomas of the 
submaxillary salivary gland have been observed in castrated A xC strain 
female rats receiving N,N-fluorenyldiacetamide and norethandrolone (Reuber, 
1960). Changes in bile canaliculi are produced by norethandrolone in human 
and rat liver (Schaffner et al., 1960). Peliosis hepatis and cholestasis have 
14 
been observed following administration of norethandrolone (Gordon et al., 
1960). 
Oxandrolone: 
Synonyms: NSC-67068; SC-11585. 
Brand/Trade name: Anavar. 
Cancer/Genotoxicity Studies: Oxandrolone and spironolactone protect 
against chronic digitoxin or indomethacin intoxication (Solymoss et a!., 1971). 
Oxandrolone has anabolic action and side effects in mental patients (Sansoy 
et al., 1971). Cases of hepatic and precocious prostate cancers have been 
linked to long term anabolic steroid abuse (Roberts and Essenhigh, 1986; 
Overly et al., 1984). It has moderate progestogenic activity and shares hepatic 
toxicity issues common to 17-alkylated steroids (IPCS, 1993). 
Trenbolone: 
Synonym: Trenbolone acetate. 
Brand/Trade names: Finajet, Finaplix. 
Cancer/Genotoxicity Studies: In utero exposure to trenbolone masculinizes 
female Sprague-Dawley rats (Hotchkiss et al., 2007). The 17beta-trenbolone 
affects delayed-type hypersensitivity and reproductive tissues in male mice 
(Hotchkiss and Nelson, 2007). A study shows that trenbolone acetate is 
teratogenic and immunotoxic in Japanese quail (Quinn et al., 2007b), 
Trenbolone delayed onset of puberty in Japanese quail males, inhibited 
cloacal gland development, and reduced male reproductive behaviors (Quinn 
et al., 2007a). Trenbolone showed genotoxic activity in the case of in vitro 
micronucleus test in SHE cells and and also the Ames test without metabolic 
activation (Marzin, 1991). Trenbolone did not demonstrate any genotoxic 
effect in the SOS-chromotest, the rec-assay and the V79 sister chromatid 
exchange test without and with metabolic activation using rat liver 
homogenates and primary rat hepatocytes (Scheutwinkel et al., 1986). 
Trenbolone can transform SHE cells in culture, independent of its hormonal 
action and without grossly damaging DNA (Schiffmann et al., 1985). Cases of 
15 
prostate and liver cancers have been associated with long term anabolic 
steroid abuse (Roberts and Essenhigh, 1986; Overly et al., 1984). 
Stanozolol: 
Synonyms: Androstanazole; Methylstanazole; NSC-43193; Win-14833. 
Brand/Trade names: Winstrol (oral), Winstrol Depot (intra-muscular). 
Cancer/Genotoxicity Studies: At high dosage, stanozolol could exert a 
proliferative effect on liver cells (Boada et al., 1999). In primary rat 
hepatocytes, DNA repair induction study v\/ith Stanozolol produced consistent 
negative responses, whereas, inconclusive responses were obtained during 
the same study with cultures of primary hepatocytes from both male and 
female human donors leading to the conclusion that sex steroids differ for 
their ability to induce DNA repair, and that their genotoxicity may be: (i) 
different in rat and human hepatocytes, (ii) dependent on the sex of the donor, 
and (iii) affected by inter-individual variability (Martelli et al., 2003). Precocious 
prostate cancer has been reported after a long term steroid abuse (Roberts 
and Essenhigh, 1986). Hepatic cancer has also been linked to anabolic 
steroidal abuse (Overly et al., 1984). The results of the study investigating the 
tumor initiating and promoting activity in two rat liver foci bioassays do not 
provide any substantial evidence of carcinogenic activity of Stanozolol in rat 
liver, even when orally administered at high doses (Ghia and Mereto, 1992). 
Testosterone propionate: 
Synonym: Testosterone. 
Brand/Trade name: Testosterone. 
Cancer/Genotoxicity Studies: The drug Testosterone propionate (TP) has 
been shown to induce cell transformation in Syrian Hamster Embryo (SHE) 
cells (Tsutsui et al., 1995). The TP treatment for a long duration leads to 
biomyoisarcomas in the vas deferens or uterus of Golden Syrian Hamsters 
(Hudson et al., 1998). This drug has an enhancing effect on phalloidin-
induced liver toxicity in mice (Muraoka et al., 1988). TP also has a direct toxic 
effect in treating cell cultures neonatally in rat (Welder et al., 1995). 
Precocious prostate cancer and liver cancer have been associated with long 
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term anabolic steroid abuse (Roberts and Essenhigh, 1986; Overly et a!., 
1984). TP shows no genotoxic activity when tested in male mice using 
chromosomal analysis of somatic and germ cells as well as RAPD-PCR 
(Hana et al, 2008). TP-treated chicken shows the development of unusual B-
cell functions which is independent of the bursa of Fabricius (Hirota et al., 
1980). TP induces prostate tumors in male Wistar-Unilever rats (Bisson et al., 
2008). 
ANTIOXIDANTS 
An antioxidant is a molecule capable of slowing or preventing the 
oxidation of other molecules. Oxidation is a chemical reaction that transfers 
electrons from a substance to an oxidizing agent. Oxidation reactions can 
produce free radicals, which start chain reactions that damage cells. 
Antioxidants terminate these chain reactions by removing free radical 
intermediates, and inhibit other oxidation reactions by being oxidized 
themselves. As a result, antioxidants are often reducing agents such as thiols 
or polyphenols. Although oxidation reactions are crucial for life, they can also 
be damaging; hence, plants and animals maintain complex systems of 
multiple types of antioxidants, such as glutathione, vitamin C, and vitamin E 
as well as enzymes such as catalase, superoxide dismutase and various 
peroxidases. Low levels of antioxidants, or inhibition of the antioxidant 
enzymes, causes oxidative stress and may damage or kill cells. The following 
is a brief review of a few natural plant products (phytochemicals) which have 
been studied for their antigenotoxic, ameliorative potential in reducing or 
preventing chromosome damage due to oxidation reactions. 
Gingerol: 
Ginger is one of the most widely used spices and has been used in 
traditional oriental medicines for long time. Its extract and major pungent 
principles have been shown to exhibit a variety of biological activities (Wei et 
al., 2005). Gingerol, or sometimes 6-gingerol, is the active constituent of fresh 
ginger. Chemically, gingerol is a relative of capsaicin, the compound that 
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gives Chile peppers their spiciness. It is normally found as pungent yellow oil, 
but also can form a low-melting crystalline solid. Cooking ginger transforms 
gingerol into zingerone, which is less pungent and has a spicy-sweet aroma. 
Gingerol may reduce nausea caused by motion sickness or pregnancy 
(Ernst and Pittler, 2000) and may also relieve migraine (Mustafa and 
Srivastava, 1990). Gingerol has been used to induce a suspended animation-
like hypothermic state in rats (Ueki et al., 2008). Gingerol-related compounds 
were found to possess significant cytotoxicity against human promyelocytic 
leukemia (HL-60) cells (IC (50) <50 microM) and the cytotoxic activity was 
associated with the cell apoptosis (Wei et al., 2005). Gingerol shows 
antihepatotoxic activity utilizing carbon tetrachloride- and galactosamine-
induced cytotoxicity in primary cultured rat hepatocytes (Hikino et al., 1985). 
Gingerol has a potential to be used as therapeutic adjuvant in cisplatin 
nephrotoxicity as it prevents cisplatin-induced acute renal failure in rats 
(Kuhad et al., 2006). Gingerol inhibits TPA-induced COX-2 expression in 
mouse skin in vivo by blocking the p38 MAP kinase-NF-kappaB signaling 
pathway (Kim et al., 2005). Gingerol significantly inhibited the tumor-promoter-
stimulated inflammation, TNF-alpha production, and activation of epidermal 
ornithine decarboxylase in mice. In another study, gingerol suppressed the 
superoxide production stimulated by TPA in differentiated HL-60 cells (Surh et 
al., 1999). Gingerol as an antioxidant was shown to protect HL-60 cells from 
oxidative stress. Moreover, it induced cell death in promyelocytic leukemia 
HL-60 cells, caused DNA fragmentation and inhibited Bcl-2 expression in HL-
60 cells (Wang et al., 2003). 
Genistein: 
Genistein is one of the several known isoflavones. Isoflavones, such as 
genistein and daidzein, are found in a number of plants, with soybeans and 
soy products like tofu and textured vegetable protein being the primary food 
source. Soy isoflavones are a group of compounds found in and isolated from 
the soybean. Besides functioning as antioxidants, many isoflavones have 
been shown to interact with animal and human estrogen receptors, causing 
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effects in the body similar to those caused by the hormone estrogen. Soy 
isoflavones also produce non-hormonal effects. 
Some isoflavones act as antioxidants to counteract damaging effects of 
free radicals in tissues. Genistein has a converse effect in this area compared 
to other isoflavones; It stimulates a step in nitrate synthesis, which is oxidation 
(Liu et al., 2004). Genistein protects against pro-inflammatory factor-induced 
vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium 
interaction, thereby modulating vascular inflammation, a major event in the 
pathogenesis of atherosclerosis (Si and Liu, 2007). 
Some isoflavones have been found to have antiangiogenic effects 
(blocking formation of nev\/ blood vessels), and may block the uncontrolled cell 
growth associated with cancer, most likely by inhibiting the activity of 
substances in the body that regulate cell division and cell survival (growth 
factors). If genistein has this effect, then it still has the net effect of promoting 
cancer in one study (Chen and Wong, 2004). The timing of phytoestrogen use 
is important as genistein makes some cells more sensitive to radio-therapy 
(De Assis and Hilakivi-Clarke, 2006). 
Though research is still ongoing, some recent studies have indicated 
that soy's phytoestrogens could be contributive factors in some forms of 
breast cancer, penile birth defects, and infantile leukemia (Hilakivi-Clarke et 
al., 1999). Some studies have raised the concern that genistein might 
increase the risk of leukemia, because it inhibits the enzyme topoisomerase 
which results in double strand DNA breaks, which are, in turn, mutagenic. 
Some cancer patients whose chemotherapy drugs inhibited topoisomerase 
later developed leukemia (Ju et al., 2006). Genistein in concentrations higher 
than 20 mM significantly reduced cell viability, caused cell morphological 
changes and induced apoptotic and necrotic cell death (Rucinska et al., 
2008). 
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Catechins: 
Catechins are polyphenolic antioxidant plant metabolites. They belong 
to the family of flavonoids and, to be more specific, flavan-3-ols. These 
compounds are abundant in tea derived from the tea-plant Camellia sinensis 
as well as in some cocoas and chocolates (made from the seeds of 
Theobroma cacao). 
Catechin and epicatechin are epimers, with (-)-epicatechin and (+)-
catechin being the most common optical isomers found in nature. Catechin 
was first isolated from the plant extract catechu, from which it derives its 
name. Heating catechin past its point of decomposition releases pyrocatechol, 
which explains the common origin of the names of these compounds. 
Epigallocatechin and gallocatechin contain an additional phenolic hydroxyl 
group when compared to epicatechin and catechin, respectively, similar to the 
difference in pyrogallol compared to pyrocatechol. Catechin gallates are gallic 
acid esters of the catechins; such as EGCG (epigallocatechin gallate), which 
is commonly the most abundant catechin in tea. 
Catechins constitute about 25% of the dry weight of fresh tea leaf 
(Balentine et al., 1998), although total catechin content varies widely 
depending on clonal variation, growing location, seasonal/ light variation, and 
altitude. They are present in nearly all teas made from Camellia sinensis, 
including white tea, green tea, black tea and Oolong tea. Catechins are also 
present in the human diet in chocolate (Hammerstone et al., 2000), fruits, 
vegetables and wine (Ruidavets et al., 2000) and are found in many other 
plant species (Harborne et al., 1975). 
Epicatechin gallate (ECG) and Epigallocatechin gallate (EGCG): 
The health benefits of catechins have been studied extensively in 
humans and in animal models. Reduction in atherosclerotic plaques was seen 
in animal models (Chyu et al., 2004). Reduction in carcinogenesis was seen 
in vitro (Mittal et al., 2004). According to one researcher (Katiyar et al.. 
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2007), epigallocatechin-3-gallate is an antioxidant that helps protect the skin 
from UV radiation-induced damage and tumor formation. Other studies have 
found that EGCG can make malignant brain tumor cells more sensitive to 
killing by the chemo-drug temozolomide in the laboratory with cultured human 
brain tumor cells (Pyrko, 2007). 
Green tea catechins have also been shown to possess antibiotic 
properties due to their role in disrupting a specific stage of the bactenal DNA 
replication process (Gradisar et al., 2007). White tea typically contains higher 
level of catechins (http://findarticles.eom/p/articles/mi_m0854/is_9_26/, 
2003). Co-treatments with EGCG and EGC, EGCG or ECG, and EGC and 
ECG have stronger synergistic effects on the protection of FK506-induced cell 
death due to nephrotoxicity (Hisamura et al., 2008). Experiments have proved 
the significant cytoprotective effects of EGCG and ECG against ochratoxin A 
(OTA)-induced cytotoxicity in a pig kidney cell line (LLC-PK1) (Costa et al., 
2007). Epigallocatechin-3-gallate was found to be effective at collapsing the 
mitochondrial membrane potential and inducing ROS formation in isolated rat 
hepatocytes (Galati et al., 2006). ECG induces apoptosis in the carcinoma 
HSC-2 cells, but not in the normal HGF-2 fibroblasts and hence this research 
supports those studies suggesting that green tea is an effective 
chemopreventive agent of oral carcinoma (Babich et al., 2005). Low 
concentrations of catechins are cytotoxic to ERalpha- human breast cancer 
cells, and the combination of EGCG and 4-OHT (tamoxifen) elicits synergistic 
cytotoxicity in MDA-MB-231 human breast cancer cells (Chisholm et al., 
2004). ECG and EGCG can reverse the multi-drug resistance of human 
hepatocellular carcinoma in vitro (Liang et al., 2004). Tea catechins inhibit 
TBARS accumulation in HepG2 cells, the order of effectiveness being (-)-
epigallocatechin gallate (EGCG) > (-)-epigallocatechin (EGC) > or = (-)-
epicatechin gallate (ECG) > (-)-epicatechin (EC) and EGCG and EGC 
protected the depletion of alpha-tocopherol in the cells while the glutathione 
content was enhanced by all four catechins (Murakami et al., 2002). Tea 
catechins protect against lead-induced cytotoxicity, lipid peroxidation, and 
membrane fluidity in HepG2 cells (Chen et al., 2002). Epigallocatechin gallate 
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is able to interfere with the cell cycle in Caco2 cell lines of human colon 
adenocarcinoma cells (Salucci et al., 2002). ECG, EGCG, and theaflavin 
strongly suppress the invasion of highly metastatic human fibrosarcoma 
HT1080 cells into the monolayer of human umbilical vein endothelial cells 
(HUVECs) and the accompanying basal membrane (Maeda-Yamamoto et al., 
1999). Epicatechin gallate and epigallocatechin gallate are active in inhibiting 
the adhesion of mouse lung carcinoma 3LL cells to the monolayer of bovine 
lung endothelial cells (Isemura et al., 1993). 
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MATERIALS AND METHODS 
Chemicals 
Stanozolol (CAS No.: 10418-03-8, Sigma-Aldrich); Trenbolone 
(CAS No.: 10161-33-8, Sigma-Aldrich); Norethandrolone (CAS No.: 52-78-
8); Oxandrolone (CAS No.: 53-39-4); Testosterone propionate (CAS No.: 57-
85-2 , Sigma-Aldrich); Gingerol (CAS No.: 23513-14-6, Sigma-Aldrich); 
Genistein (CAS No.: 446-72-0, Sigma-Aldrich); Epicatechin-3-gallate (CAS 
No.: 1257-08-5, Sigma-Aldrich); Epigallocatechin-3-gallate (CAS No.: 989-
51-5, Sigma-Aldrich); RPMl 1640 (GIBCO, Invitrogen); Phytohaemagglutinin-
M (GIBCO, Invitrogen); Antibiotic-antimycotic mixture (GIBCO, Invitrogen); 
Fetal serum - calf (GIBCO, Invitrogen); 5-bromo-2-deoxyuridine (Sigma-
Aldrich); Hoechst 33258 stain (Sigma-Aldrich); Giemsa stain (Merck); 
Mitomycin-C (Sigma-Aldrich); Cyclophosphamide (Sigma-Aldrich); Methyl 
methanesulphonate (Sigma-Aldrich); Sodium phenobarbitone (Sigma-Aldrich); 
Colchicine (Microlab); Dimethyl sulphoxide (Merck); NADP (SRL). 
Human lymphocyte culture 
Duplicate peripheral blood cultures were conducted according to 
Carballo et al. (1993). Briefly, 0.5 ml of the heparinized blood samples were 
obtained from a healthy female donor and placed subsequently in a sterile 
flask containing 7 ml of RPMl 1640, supplemented with 1.5 ml of fetal calf 
serum and 0.1 ml of phytohaemagglutinin. These flasks were placed in an 
incubator at 37°C for 24 hours. Untreated culture and also negative and 
positive controls were run simultaneously. 
GENOTOXICITY STUDIES WITH STEROIDS 
(i) Stanozolol 
Chromosomal aberration analysis 
Stanozolol at 1, 10, 20, 40 and 60 i^M concentrations respectively was 
dissolved in dimethylsulphoxide and was added later after 24 h. The cells 
were cultured for another 48 h at 37°C keeping them in an incubator. For 
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metabolic activation experiments, 0.5 ml of S9 mix dose was added to the 
stanozolol treatment. S9 mix was prepared from the liver of healthy rats 
(Wistar strain) as per standard procedure of Maron and Ames (1983). The S9 
fraction so obtained was enhanced by addition of 5 |aM of NADP and 10 |a.M of 
glucose-6-phosphate just before the use to make the S9 mix. The S9 mix 
without NADP was also given with each of the tested dose of stanozolol. An 
amount of 0.2 ml of colchicine (0.2 |ig/ml) was added to the culture flask, 1 h 
prior to harvesting. Cells were centrifuged at 1000 rpm for 10 min. The 
supernatant was removed and 5 ml of prewarmed (37°C) 0.075 M KCI 
(hypotonic solution) was added. Cells were resuspended and incubated at 
37°C for 15 min. The supernatant was removed by centrifugation, and, 
subsequently 5 ml of chilled fixative (methanol: glacial acetic acid, 3:1) was 
added. The fixative was removed by centrifugation and the procedure was 
repeated twice. To prepare slides, 3-5 drops of the fixed cell suspension were 
dropped on clean slides and air-dried. The slides were stained in 3% Giemsa 
solution in phosphate buffer (pH 6.8) for 15 min. Three hundred metaphases 
were examined for screening the presence of different types of abnormality. 
Criteria to classify different types of aberrations were in accordance with the 
recommendation of Environmental Health Committee 46 for Environmental 
Monitoring of Human Populations (IPCS, 1985). 
Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromo-deoxyuridine (BrDU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h, stanozolol at final 
concentrations of 1, 10, 20, 40 and 60 [iM, earlier dissolved in 
dimethylsulphoxide, was added and kept for another 48 h at 37°C in an 
incubator. For metabolic activation experiments, 0.5 ml of S9 mix with and 
without NADP was given along with each of the tested dose. Mitotic arrest 
was attempted, 1 h prior to harvesting by adding 0.2 ml of colchicine (0.2 
|ig/ml). Hypotonic treatment and fixation were done in the same way as 
described for chromosomal aberration analysis. The slides were processed 
according to Perry and Wolff (1974), and Afzal and Azfer (1994). The sister 
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chromatid exchange induction was analysed from 50 plates of second division 
mitoses per dose. 
(ii) Trenbolone 
Chromosomal aberration analysis 
After 24 h of the initiation of culture, trenbolone was added at 
concentrations of 1, 10, 20, 40 and 60 jiM (dissolved in dimethyl-sulphoxide). 
The cells were cultured for another 48 h at 37°C in the incubator. One hour 
prior to harvesting, 0.2 ml of colchicine (0.2 |ag/ml) was added to the culture 
flask. Cells were centrifuged at 1000 rpm for 10 min. The supernatant was 
removed and 5 ml of 0.075 M KCI (hypotonic solution prewarmed at 37°C) 
was added subsequently. Cells were resuspended and incubated at 37°C for 
15 min. The supernatant was removed by centrifugation to which 5 ml of 
chilled fixative (methanol; glacial acetic acid; 3:1) was added later. The 
fixative was removed by centrifugation and the procedure was repeated twice. 
Slides were prepared and stained in 3% Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. Three hundred metaphases were examined for recording 
the occurrence of different types of abnormality i.e. gaps, fragments and 
breaks. 
Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|.ig/ml) was added at the beginning of the culture. After 24 h, trenbolone was 
added at final concentrations of 1, 10, 20, 40 and 60 i^M (dissolved in 
dimethylsulphoxide) and kept for another 48 h at 37°C in the incubator. Mitotic 
arrest was attempted 1 h prior to harvesting by adding 0.2 ml of colchicine 
(0.2 |ag/ml). Hypotonic treatment and fixation followed in the same way as 
described for chromosomal aberration analysis. The slides were processed 
according to Perry and Wolff (1974). The sister chromatid exchange induction 
was analyzed in metaphase from second cycle after treatment. 
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(Hi) Norethandrolone 
Chromosomal aberration analysis 
After 24 h of initiation of the culture, noretliandroJone was added at 5, 
10, 20, 30 and 40 )aM (dissolved in dimethylsulphoxide). For metabolic 
activation experiments, the tested doses of norethandrolone (dissolved in 
dimethylsulphoxide) were given along with 0.5 ml of S9 mix. The cells were 
cultured for another 48 h at 37°C in an incubator. Harvesting, hypotonic 
treatment, fixation and slide preparation were done as described earlier in the 
text. Three hundred metaphases were examined for the occurrence of 
different types of abnormality. 
Sister chiromatid exchange analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
iag/ml) was added at the beginning of the culture. After 24 h of initiation of the 
culture, norethandrolone dissolved in dimethylsulphoxide at 5, 10, 20, 30 and 
40 \M of concentrations was used. For metabolic activation experiments, the 
tested doses were given along with 0.5 ml of rat liver microsomal fraction (S9 
mix). Dimethylsulphoxide (5 i^ l/ml) was taken as negative control. Mitomycin C 
(0.3 ng/ml) was taken as positive control. Harvesting, hypotonic treatment and 
fixation were done (as described earlier in the text). The slides were 
processed according to Perry and Wolff (1974) and stained for 20 min in a 
0.05% (w/v), Hoechst 33258 solution and rinsed with tap water and placed 
under a UV lamp for 90 min, covered with Sorensen's buffer (pH 6.8) and 
stained with 3% Giemsa solution in phosphate buffer (pH 6.8) for 15 min. The 
sister chromatid exchange average was taken from an analysis of the 
metaphases during second cycle of division. 
(iv) Oxandrolone 
Chromosomal aberration analysis 
After 24 h, oxandrolone was added at final concentrations of 5, 10, 20, 
30 and 40 |aM dissolved in dimethylsulphoxide and kept at 37°C in the 
incubator for another 48 h. Harvesting, hypotonic treatment, fixation and slide 
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preparation were done as described earlier in the text. Three hundred 
metaphases were examined for the occurrence of different types of 
abnormality i.e. gaps, fragments and breaks. 
Sister chromatid exctiange analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
ng/ml) was added at the beginning of the culture. After 24 h, oxandrolone at 
final concentrations of 5, 10, 20, 30 and 40 |aM (dissolved in 
dimethylsulphoxide) was added and kept for another 48 h at 37°C in the 
incubator. Harvesting, hypotonic treatment, fixation and processing of slides 
were done as described earlier in the text. 
(v) Testosterone propionate 
Chiromosomal aberration analysis 
After 24 h, testosterone propionate was added at final concentrations 
of 10, 20 and 40 \xM dissolved in dimethylsulphoxide and kept at 37°C in the 
incubator for another 48 h. Harvesting, hypotonic treatment, fixation and slide 
preparation were done as described earlier in the text. Three hundred 
metaphases were examined for the occurrence of different types of 
abnormality i.e. gaps, fragments and breaks. 
Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h, testosterone 
propionate at final concentrations of 10, 20 and 40 |aM (dissolved in 
dimethylsulphoxide) was added and kept for another 48 h at 37°C in the 
incubator. Harvesting, hypotonic treatment, fixation and processing of slides 
were done as described earlier in the text. 
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STUDIES WITH NATURAL PLANT PRODUCTS 
(i) Gingerol 
(a) Chromosomal aberration analysis in human lymphocytes treated with 
MMS in the absence and presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, methyl 
methanesulphonate (60 |iM) was administered, with 5, 10 and 20 iiM of 
gingerol respectively and kept for 48 h at 38°C in the incubator. Prior to 1 h of 
harvesting, 0.2 ml of colchicine (0.2 ng/ml) was added to the culture flasks. 
Hypotonic treatment, fixation and processing of slides were done as described 
earlier in the text. Three hundred metaphases were examined for the 
presence of different types of abnormality i.e. gaps, breaks and exchanges. 
Critena to classify the different types of aberrations were in accordance with 
the recommendation of EHC 46 for Environmental Monitoring of Human 
Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 60 |aM of MMS separately and along with 5, 10 and 20 \iM of gingerol 
was treated and kept for 48 h at 37°C in the incubator. Mitotic arrest was done 
one hour prior to harvesting by adding 0.2 ml of colchicine (0.2 ^g/ml). 
Hypotonic treatment and fixation were performed in the same way as 
described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
(b) Chromosomal aberration analysis in human lymphocytes treated with 
norethandrolone 
After 24 h of incubation of human lymphocyte culture, norethandrolone 
(30 and 40 |aM) was administered, with 20 and 30 i^ M of gingerol respectively 
and kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of 
colchicine (0.2 |ag/ml) was added to the culture flasks. Hypotonic treatment, 
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fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
ng/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 30 and 40 fiM of norethandrolone separately and along with 20 and 
30 \xM of gingerol was treated and kept for 48 h at 37°C in the incubator. 
Mitotic arrest was done one hour prior to harvesting by adding 0.2 ml of 
colchicine (0.2 |ag/ml). Hypotonic treatment and fixation were performed in the 
same way as described earlier in the text. The slides were processed 
according to Perry and Wolff (1974). Sister chromatid exchange average was 
taken from an analysis of 50 second division metaphases. 
(c) Chromosomal aberration analysis in human lymphocytes treated with 
oxandrolone 
After 24 h of incubation of human lymphocyte culture, oxandrolone (30 
and 40 fiM) was administered, with 20 and 30 ]xM of gingerol respectively and 
kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of 
colchicine (0.2 |ig/ml) was added to the culture flasks. Hypotonic treatment, 
fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 30 and 40 fiM of oxandrolone separately and along with 20 and 30 i^ M 
of gingerol was treated and kept for 48 h at 37°C in the incubator. Mitotic 
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arrest was done one hour prior to harvesting by adding 0.2 ml of colchicine 
(0.2 i^g/ml). Hypotonic treatment and fixation were performed in the same way 
as described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). The sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
(ii) Genistein 
(a) Chromosomal aberration analysis in human lymphocytes treated with 
MMS in the absence of S9 mix 
After 24 h of incubation of human lymphocyte culture, 
methylmethanesulphonate (60 fiM) was administered, with 25 and 40 |iM of 
genistein treatment respectively and was kept for 48 h at 38°C in the 
incubator. Prior to 1 h of harvesting, 0.2 ml of colchicine (0.2 |ig/ml) was 
added to the culture flasks. The hypotonic treatment, fixation and processing 
of slides were done as described earlier in the text. Three hundred 
metaphases were examined for the occurrence of different types of 
abnormality i.e. gaps, breaks and exchanges. Criteria to classify the different 
types of aberrations were in accordance with the recommendation of EHC 46 
for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
fig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 60 |J.M of MMS separately and along with 25 and 40 |j.M of genistein 
was treated and kept for 48 h at 37°C in the incubator. Mitotic arrest was done 
one hour prior to harvesting mainly by adding 0.2 ml of colchicine (0.2 ng/ml). 
Hypotonic treatment and fixation were performed in the same way as 
described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). The sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
30 
(b) Chromosomal aberration analysis in human lymphocytes treated with 
cyclophosphamide in the presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, the 
cyclophosphamide (0.16 |ig/ml) was administered, with 25 and 40 |iM of 
genistein respectively and kept for 48 h at 38°C in the incubator. Prior to 1 h of 
harvesting, 0.2 ml of colchicine (0.2 |ig/ml) was added to the culture flasks. 
Hypotonic treatment, fixation and processing of slides were done as described 
earlier in the text. Three hundred metaphases were examined for the 
occurrence of different types of abnormality i.e. gaps, breaks and exchanges. 
Criteria to classify the different types of aberrations were in accordance with 
the recommendation of EHC 46 for Environmental Monitoring of Human 
Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
ng/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 0.16 |ag/ml of cyclophosphamide separately and along with 25 and 40 
\iM of genistein was treated and kept for 48 h at 37°C in the incubator. Mitotic 
arrest was done one hour prior to harvesting by adding 0.2 ml of colchicine 
(0.2 |j.g/ml). Hypotonic treatment and fixation were performed in the same way 
as described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
(c) Chromosomal aberration analysis in human lymphocytes treated with 
norethandrolone 
After 24 h of incubation of human lymphocyte culture, norethandrolone 
(30 and 40 i^ M) was administered, with 30 and 40 |aM of genistein respectively 
and kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of 
colchicine (0.2 |ig/ml) was added to the culture flasks. Hypotonic treatment, 
fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
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different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental IVIonitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 30 and 40 |aM of norethandrolone separately and along with 30 and 
40 |aM of genistein was treated and kept for 48 h at 37°C in the incubator. 
Mitotic arrest was done one hour prior to harvesting by adding 0.2 ml of 
colchicine (0.2 |ig/ml). Hypotonic treatment and fixation were performed in the 
same way as described earlier in the text. The slides were processed 
according to Perry and Wolff (1974). The average of sister chromatid 
exchange was taken from an analysis of 50 second division metaphases. 
(d) Chromosomal aberration analysis in human lymphocytes treated with 
oxandrolone 
After 24 h of incubation of human lymphocyte culture, oxandrolone (30 
and 40 i^ M) was administered, with 30 and 40 |iM of genistein respectively 
and kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of 
colchicine (0.2 fag/ml) was added to the culture flasks. Hypotonic treatment, 
fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|j,g/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 30 and 40 |iM of oxandrolone separately and along with 30 and 40 [iM 
of genistein was added and kept for 48 h at 37°C in the incubator. Mitotic 
arrest was attempted one hour prior to harvesting by adding 0.2 ml of 
colchicine (0.2 ^g/ml). Hypotonic treatment and fixation were performed in the 
same way as described earlier in the text. The slides were processed 
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according to Perry and Wolff (1974). Sister chromatid exchange average was 
taken from an analysis of a total of 50 second division metaphases. 
(iii) Epicatechin gallate (ECG) 
Chromosomal aberration analysis in human lymphocytes treated with 
testosterone propionate in the presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, testosterone 
propionate (20 and 40 )iM) was administered, with 20, 30 and 40 )aM of ECG 
respectively and kept for 48 h at 38°C in the incubator. Prior to 1 h of 
harvesting, 0.2 ml of colchicine (0.2 |ag/ml) was added to the culture flasks. 
Hypotonic treatment, fixation and processing of slides were done as described 
earlier in the text. Three hundred metaphases were examined for the 
occurrence of different types of abnormality i.e. gaps, breaks and exchanges. 
Criteria to classify the different types of aberrations were in accordance with 
the recommendation of EHC 46 for Environmental Monitoring of Human 
Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 20 and 40 |j.M of testosterone propionate separately and along with 
20, 30 and 40 i^M of ECG were treated and kept for 48 h at 37°C in the 
incubator. Mitotic arrest was done one hour prior to harvesting by adding 0.2 
ml of colchicine (0.2 i^g/ml). Hypotonic treatment and fixation were performed 
in the same way as described earlier in the text. The slides were processed 
according to Perry and Wolff (1974). Sister chromatid exchange average was 
taken from an analysis of 50 second division metaphases. 
(iv) Epigallocatechin gallate (EGCG) 
Chromosomal aberration analysis in human lymphocytes treated with MMS in 
the absence of S9 mix 
After 24 h of incubation of human lymphocyte culture, MMS (60 fiM) 
was administered, with 10, 20, and 30 |aM of EGCG respectively and kept for 
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48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of colchicine 
(0.2 |ig/ml) was added to the culture flasks. Hypotonic treatment, fixation and 
processing of slides were done as described earlier in the text. Three hundred 
metaphases were examined for the occurrence of different types of 
abnormality i.e. gaps, breaks and exchanges. Criteria to classify the different 
types of aberrations were in accordance with the recommendation of EHC 46 
for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchiange analysis in tiuman lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
l^ g/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 60 ^M of MMS separately and along with 10, 20, and 30 [iM of EGCG 
were treated and kept for 48 h at 37°C in the incubator. Mitotic arrest was 
done one hour prior to harvesting by adding 0.2 ml of colchicine (0.2 lag/mi). 
Hypotonic treatment and fixation were performed in the same way as 
described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
Chromosomal aberration analysis in human lymphocytes treated with CP in 
the presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, CP (0.16 |ig/ml) 
was administered, with 10, 20, and 30 ^M of EGCG respectively and kept for 
48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of colchicine 
(0.2 fxg/ml) was added to the culture flasks. Hypotonic treatment, fixation and 
processing of slides were done as described earlier in the text. Three hundred 
metaphases were examined for the occurrence of different types of 
abnormality i.e. gaps, breaks and exchanges. Criteria to classify the different 
types of aberrations were in accordance with the recommendation of EHC 46 
for Environmental Monitoring of Human Population (IPCS, 1985). 
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Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/nnl) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 0.16 |ig/ml of CP separately and along with 10, 20, and 30 i^ M of 
EGCG were treated and kept for 48 h at 37°C in the incubator. Mitotic arrest 
was done one hour prior to harvesting by adding 0.2 ml of colchicine (0.2 
fig/ml). Hypotonic treatment and fixation were performed in the same way as 
described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
Chromosomal aberration analysis in human lymphocytes treated with 
Stanozolol in the absence as well as presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, Stanozolol (40 
and 60 ]xM) was administered, with 20 and 30 i^ M of EGCG respectively and 
kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 ml of 
colchicine (0.2 fag/ml) was added to the culture flasks. Hypotonic treatment, 
fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes in the absence as 
well as presence of S9 mix 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
|ig/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 40 and 60 |aM of Stanozolol separately and along with 20 and 30 iiM 
of EGCG were treated and kept for 48 h at 37°C in the incubator. Mitotic 
arrest was done one hour prior to harvesting by adding 0.2 ml of colchicine 
(0.2 ^g/ml). Hypotonic treatment and fixation were performed in the same way 
as described earlier in the text. The slides were processed according to Perry 
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and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
Chromosomal aberration analysis in human lymphocytes treated with 
Trenbolone in the absence as well as presence of S9 mix 
After 24 h of incubation of human lymphocyte culture, Trenbolone (40 
and 60 |aM) was administered, with 20 and 30 fj,M of EGCG respectively and 
kept for 48 h at 38°C in the incubator. Prior to 1 h of harvesting, 0.2 mi of 
colchicine (0.2 iig/ml) was added to the culture flasks. Hypotonic treatment, 
fixation and processing of slides were done as described earlier in the text. 
Three hundred metaphases were examined for the occurrence of different 
types of abnormality i.e. gaps, breaks and exchanges. Criteria to classify the 
different types of aberrations were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human Population (IPCS, 1985). 
Sister chromatid exchange analysis in human lymphocytes in the absence as 
well as presence of S9 mix 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 10 
f^g/ml) was added at the beginning of the culture. After 24 h of the initiation of 
culture, 40 and 60 }iM of Trenbolone separately and along with 20 and 30 |iM 
of EGCG were treated and kept for 48 h at 37°C in the incubator. Mitotic 
arrest was done one hour prior to harvesting by adding 0.2 ml of colctiicine 
(0.2 jig/ml). Hypotonic treatment and fixation were performed in the same way 
as described earlier in the text. The slides were processed according to Perry 
and Wolff (1974). Sister chromatid exchange average was taken from an 
analysis of 50 second division metaphases. 
Statistical Analysis 
Student's two tailed Mest was used for the analysis of chromosomal 
aberrations and sister chromatid exchanges. The level of significance was 
tested from standard statistical tables of Fisher and Yates (1963). 
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RESULTS 
The chromosomal aberrations were studied as gaps, chromatid breaks, 
chromosomal breaks, chromatid exchanges and dicentrics. In case of without 
S9 mix (Table 1; Fig.1; Graph 1), there is a distinct increase in total breaks 
due to methylmethane sulphonate (0.67% in control to 33%). However, the 
breaks get reduced from 19% to 7% with the addition of increasing 
concentrations of gingerol. Gingerol alone shows lower percentage of breaks 
(0.66-1.67%) with increase in concentrations, which is just higher than the 
control. In the presence of S9 mix (Table 3; Fig. 3; Graph 3), the breaks are 
slightly increased and the control remains the same. With MMS and with the 
combination of gingerol and MMS, the number of breaks stays low, thus 
indicating weaker action of the mutagen. 
The number of SCEs gets increased due to the presence of MMS (17% 
compared to 2% in control). The effect of MMS gets reduced with the addition 
of gingerol from 7.8% to 5%. Gingerol alone shows lower number of SCEs 
(Table 2; Fig. 2; Graph 2). In the presence of S9 mix, the results follow the 
same trend and the effect is more pronounced as compared to one without S9 
mix (Table 4; Fig. 4; Graph 4). 
A similar pattern was observed during CA induction, in the absence as 
well as presence of metabolic activation. This was found true for both MMS 
and cyclophosphamide (CP) induced CAs and the dose-dependent decrease 
in CAs on treatment with genistein (Tables 5 and 6; Fig. 5, 6). Overall, the 
number of abnormal cells got lowered. 
During SCE analysis, a similar result was obtained. Both MMS and CP 
showed a substantial increase in SCEs. Dose-dependent increase in SCEs 
was observed when only genistein was used for treatment. Significant 
decrease in SCEs was noticed when genistein was used against MMS and 
CP, respectively (Table 7; Fig. 7, 8). 
The number of abnormal cells with CAs was insignificantly low at 1, 10 
and 20 JJLM respectively, both for stanozolol and trenbolone, being tested for 
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genotoxicity, in the presence as well as absence of metabolic activation 
system i.e. S9 mix (Tables 8, 9, 10 and 11; Fig. 9, 10, 11, 12; Graphs 5, 6, 7 
and 8). A dramatic increase in genotoxic damage was observed when the 
dose was increased to 40 and 60 \xM, and the abnormal cells got more than 
doubled although the dose-dependent increase in CAs was small from 40 to 
60 ^ iM. 
The SCE frequency in human lymphocytes treated separately with 
stanozolol and trenbolone (Tables 12, 13, 14 and 15; Fig. 13, 14, 15, 16; 
Graphs 9, 10, 11 and 12), with and without S9 mix, followed a pattern similar 
to the one observed in the case of CAs. At dosage of 1, 10 and 20 |iM, the 
SCE frequency remained quite low and showed little increase, but as the dose 
increased to 40 i^ M, and then to 60 ^M, a more than three fold increase in 
SCEs for cells was observed. Again the dose-dependent rise in SCE 
frequency was small going from 40 to 60 laM. 
Both genistein and gingerol proved to be equally effective in reducing 
the number of abnormal cells with CAs induced by norethandrolone and 
oxandrolone at all of their tested doses. A significant increase in CAs was 
observed at 30 and 40 \iM of both norethandrolone and oxandrolone (Tables 
16, 17, 18 and 19; Fig. 17, 18, 19, 20; Graphs 13 and 14). The dose-
dependent increase in CAs was not much different from 30 to 40 \xM. 
A dose-dependent decrease in number of abnormal metaphases was 
observed when the genotoxic doses of norethandrolone were added with 30 
and 40 fiM of genistein and 20 and 30 ^M of gingerol (Tables 16 and 17; Fig. 
17 and 18; Graph 13). The selected dosage of genistein and gingerol was not 
genotoxic itself (Tables 16, 17, 18 and 19; Fig. 17, 18, 19, 20; Graphs 13 and 
14). Similar dose-dependent decrease in number of abnormal metaphases 
was observed when the genotoxic doses i.e. 30 and 40 fiM oxandrolone was 
treated with 30 and 40 |iM of genistein and 20 and 30 |iM of gingerol 
respectively (Tables 18 and 19; Fig. 19 and 20; Graph 14). 
For sister chromatid exchange analysis, a significant increase in 
SCEs/cell was observed at 30 and 40 \iM of norethandrolone and 
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Graph 7: Trenbolone induced CAs in human lymphocytes in the absence of 
metabolic activation. 
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metabolic activation. 
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Graph 9: Stanozolol induced SCEs in human lymphocytes in the absence of 
metabolic activation. 
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Graph 10: Stanozolol induced SCEs in human lymphocytes in the presence of 
metabolic activation. 
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Graph 12: Trenbolone induced SCEs in human lymphocytes in the presence of 
metabolic activation. 
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Graph 13: CAs induced by norethandrolone in cultured human lymphocytes. 
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Graph 14: CAs induced by oxandrolone in cultured human lymphocytes. 
74 
oxandrolone respectively (Tables 20, 21, 22 and 23; Fig. 21, 22, 23, 24; 
Graphs 15 and 16). A significant decrease in SCEs/cell was observed when 
30 and 40 |.iM of norethandrolone was treated with 30 and 40 ^M genistein 
and 20 and 30 ^M of gingerol (Tables 20 and 21; Fig. 21 and 22; Graph 15). 
Similar trend was observed when 30 and 40 |iM of oxandrolone was treated 
with 30 and 40 ]xM of genistein and 20 and 30 |iM of gingerol respectively 
(Tables 22 and 23; Fig. 23 and 24; Graph 16). The selected dosage of 
gingerol and genistein did not induce increased level of SCEs/cell significantly 
as compared to the untreated one (Tables 20, 21, 22 and 23; Fig. 21, 22, 23, 
24; Graphs 15 and 16). 
The principle TP was not genotoxic in the absence of metabolic 
activation (Tables 24 and 26; Fig. 25 and 27; Graphs 17 and 20). A significant 
increase in CAs was observed in the presence of metabolic activation at 20 
and 40 ]xM of TP in a dose-related manner. ECG proved to be effective in 
reducing the number of abnormal cells with CAs induced by TP at the tested 
dosage. A dose-dependent decrease in number of abnormal metaphases was 
observed when 20 and 40 laM of TP was treated with 20, 30 and 40 laM of 
ECG. The selected dosage of ECG was not genotoxic itself (Tables 25 and 
27; Fig. 26 and 28; Graphs 18, 19, 21, 22 and 23). During SCE analysis, a 
significant increase in SCEs was observed at 20 and 40 i^ M of TP, while a 
significant decrease in SCEs was observed when 20 and 40 \xM of TP was 
used along with 20, 30 and 40 laM of ECG. The selected dosage of ECG itself 
did not induce SCEs significantly enough and hence was not found genotoxic 
(Table 27; Fig. 28; Graphs 21, 22 and 23). 
EGCG proved its worth as an antimutagenic agent in substantially 
reducing the CAs induced by MMS in the absence of metabolic activation and 
also those induced by CP in the presence of metabolic activation, but EGCG 
was more effective in ameliorating the genotoxic damage in the case of CP 
when metabolic activation system was used (Table 28 and 29; Fig. 29 and 30; 
Graph 24). A similar pattern was observed for EGCG when SCEs were 
induced by MMS without S9 mix and by CP with S9 mix (Table 30 and 31; 
Fig. 31 and 32; Graph 25 and 26). In the case of CAs induced by stanozolol in 
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Graph 15: SCEs induced by norethandrolone in cultured human lymphocytes. 
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Graph 16: SCEs induced by oxandrolone in cultured human lymphocytes. 
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Graph 17: CAs induced by TP in cultured human lymphocytes and effect of 
ECG on CA frequency in the absence of metabolic activation. 
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Graph 18: CAs induced by TP in cultured human lymphocytes in the presence of 
metabolic activation. 
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Graph 19: CAs induced by TP in cultured human lymphocytes and effect of 
ECG on CA frequency in the presence of metabolic activation. 
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Graph 20: SCEs induced by TP in cultured human lymphocytes in the absence of 
metabolic activation. 
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Graph 21: SCEs induced by TP in cultured human lymphocytes in the presence 
of metabolic activation. 
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Graph 22: SCEs induced by TP (20 (iM) in cultured human lymphocytes and 
effect of ECG on SCE frequency in the presence of metabolic activation. 
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99 
cultured human lymphocytes in the absence as well as presence of metabolic 
activation, EGCG again proved to be more effective in reducing chromosome 
damage when applied in the presence of metabolic activation system (Table 
32 and 33; Fig. 33 and 34). Trenbolone induced CAs were observed to have a 
lower frequency of occurrence when treated with EGCG both in the absence 
and presence of S9 mix, with an almost similar pattern in the ability of EGCG 
to reduce genotoxicity, both without and with metabolic activation (Table 34 
and 35; Fig. 35 and 36). When SCEs were induced using stanozolol and 
trenbolone as toxic agents both in the absence and presence of metabolic 
activation system and EGCG was again used as the ameliorating 
antimutagenic agent, a very similar pattern was observed in the antigenotoxic 
potential of EGCG, with only slight differences obtained between the 
observations in the cases of absence and presence of S9 mix (Table 36-39; 
Fig. 37-40). Thus EGCG, by itself, was observed to be not genotoxic when 
tested for genotoxicity in all experiments performed, with or without metabolic 
activation (Tables 28-39; Fig. 29-40; Graph 24-26). 
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DISCUSSION 
Lee et al. (1986) studied the antioxidant activity of ginger. Cao et al. 
(1993) reported the scavenging effects of ginger on superoxide anion, and 
hydroxyl radical and hence the activity of 6-gingerol may be to scavenge 0^, 
v\/hich has already been reported in case of hypoxanthine oxidase systenn and 
the OH radical under UV exposure to H2O2 system. The scavenging effect of 
O; and OH' may, in fact, contribute toward explaining the pharmacological 
action of 6-gingerol (Lee et al., 1998) and determining the antitumor 
promotional activity of 6-gingerol, the major pungent principle of ginger, using 
a two-stage mouse skin carcinogenesis model. Application of 6-gingerol onto 
shaven backs of female ICR mice prior to each topical dose of 12-0-
Tetradecanoyl Phorbor-13-Acetate (TPA), significantly inhibited 7, 12-dimethyl 
benz [a] anthracene-induced skin papillomaganesis. The compound also 
suppressed TPA-induced epidermal ornithine decarboxylase activity and 
inflammation. The antioxidant activity of 6-gingerol can further be studied with 
other assay systems. 
Both neoplastic and mutagenic properties have been observed in MMS 
which is a monofunctional alkylating agent. It alkylates DNA at the N-7 
position of guanine and the N-3 position of adenine. All these changes may 
give rise to abnormal base pairing at DNA replication (Mittal and Musarrat, 
1990; Madrigal-Bujaidar et al., 1998). The production of methylguanosine 
lesions is attributed to the SCE end point, the lesions being related to tumor 
formation (Swenberg et al., 1985). SCE induction by MMS has been studied 
in earlier experiments with human lymphocytes showing positive results 
(Craig-Holmes and Shaw, 1977). CP is also an alkylating agent and after 
metabolic activation, it produces active mutagenic metabolic product 
phospharamide mustard (Ghaskadbi et al., 1992). It reacts with electron-rich 
area of susceptible molecules such as the DNA proteins (Krishna et al., 
1986). 
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In this study, genistein is observed to lower the CAs and SCEs in MMS 
and CP induced genotoxicity, in the absence and also the presence of S9 mix 
in culture, respectively. Genistein may behave as free radical scavenger and 
hence, might react with metabolites which are carcinogenic before they are 
able to inflict DNA damaging effects. Inhibition of multiplication of neoplatic 
cells, including those in breasts, has been reported for genistein 
(Lamartiniere, 2000). 
The results obtained in this study on genistein, a flavonoid, support the 
work done till now on natural products (especially genistein) in relation to their 
chemopreventive potential to reduce the genotoxicity induced by carcinogenic 
compounds. Therefore, genistein and other similar phytochemicals may be 
utilized commercially for pharmaceutical research as a model for 
chemopreventive drugs. 
The use of stanozolol in sports is illegal and banned by the 
International Association of Athletics Federations. It enjoys large oral 
bioavailability due to a C17 alpha-alkylation which allows the hormone to 
survive first pass of liver metabolism. High doses of stanozolol could exert a 
proliferative effect on liver cells (Boada et al., 1999). Acute overdosage can 
produce nausea and gastrointestinal upset. Chronic use of stanozolol can 
cause menstrual irregularities and virilization in women, while impotence, 
premature cardiovascular disease and prostatic hypertrophy in men. 
Precocious prostatic cancer has been described after long term anabolic 
steroid abuse (Roberts and Essenhigh, 1986). Cases where hepatic cancers 
have been associated with anabolic steroid abuse have been reported (Overly 
et al., 1984). Also, androgen ingestion by a pregnant mother can cause 
virilization of a female fetus (Dewhurst and Gordon, 1984). 
The trenbolone compounds have a binding affinity for the androgen 
receptor thrice as high as that of testosterone. Once metabolized, the drugs 
have the effect of increasing nitrogen uptake by muscles, leading to an 
increase in the secondary effects of stimulating appetite, reducing the amount 
of fat being deposited in the body, and decreasing the rate of catabolism. 
Some short term side effects include insomnia, high blood pressure and 
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increased aggression and libido. However, women suffer virilization effects 
even at small doses (http://en.wikipedia.org/wiki/trenbolone, 2007). 
The only legitimate therapeutic indications for such anabolic steroids 
are in the replacement of male sex steroids in men who have androgen 
deficiency, e.g. due to loss of both the testes, in the treatment of certain forms 
of rare aplastic anaemia which are or may be responsive to anabolic 
androgens and, in case of certain countries to counteract catabolic states, e.g. 
after major trauma. 
This experiment implies that the synthetic anabolic steroids, stanozolol 
and trenbolone, have the potential to cause genotoxic damage in human 
lymphocytes in vitro at higher dosage both in the presence and absence of S9 
mix. Changes in chromosome structure due to a break or a swapping of 
chromosomal material are termed as CAs. Most of the CAs in cells are lethal, 
but many of them are also viable and can cause genetic effects, either 
somatic or inherited (Swierenga et al., 1991).These events can lead to the 
loss of chromosomal material at mitosis or to the inhibition of exact 
chromosome segregation at anaphase. The result of these changes is cell 
lethality (Tucker and Preston, 1996). In our experiment, we came across 
significant differences compared with control in the CA frequency at 40 and 60 
ia.M, with or without S9 mix. SCE is usually a more sensitive indicator of 
genotoxic effects than CA (Tucker and Preston, 1996). There is a correlation 
between the carcinogenicity and SCE inducing ability of many chemicals. 
Moreover, the SCE induction mechanism is heterogeneous and very different 
from the mechanism of CA induction (Gebhart, 1981). Androgenic steroids 
display teratogenic effects in all species that have been studied so far, and do 
so in a very predictable and consistent way (Juchau, 1997). Various 
psychological and physiological effects have been reported in both males and 
females among frequent users of androgens (McEvoy, 1995). There is little, if 
any, information available on the exact reasons for the genotoxic behavior of 
stanozolol and trenbolone. However, the present study is concurrent with the 
studies performed on synthetic steroids such as cyproterone acetate, 
ethynodiol diacetate, chlormadinone acetate, medroxyprogesterone acetate, 
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norgestrel and megestrol acetate that induced CAs and SCEs with or without 
metabolic activation system (Ahmad et al., 2001; Hundal et a!., 1997; 
Siddique and Afzal, 2004a,b,c,d; Siddique et al., 2005a,b). 
The outcome of most investigative experiments shows that stanozolol 
and trenbolone have the potential to be genotoxic and cytotoxic, especially at 
40 and 60 jiM, with or without metabolic activation, in cultured human 
lymphocytes. The evaluation of these genotoxicity tests is a useful tool for 
determining the toxic effects of potentially genotoxic chemicals, leading to 
identification of such carcinogenic agents. It is advisable to use the steroids 
studied here at their lowest effective dosage so that the risk to public health 
could be minimized. The risk of damage to human genetic material is a likely 
outcome of higher doses of these drugs. 
Genistein is particularly effective in quenching free radicals produced 
by toxic agents and protects cells against oxidative damage especially with 
respect to DNA (Foti et al., 2005; Lee et al., 2000). It is a common precursor 
in the biosynthesis of antimicrobial phytoalexins and phytoanticiplns in 
legumes, and an important nutraceutical molecule. It is also capable of 
inhibiting lipoprotein oxidation in vitro and suppressing formation of plasma 
lipid oxidation products in vivo. Extracts of ginger (including gingerol) have 
antioxidant activity through scavenging of superoxide and hydroxyl radicals 
and by inhibiting lipid peroxidation (Kikuzaki and Nakatani, 1993). It is also 
antibacterial, antifungal and used for common cold (Bode et al., 2001). The 
potency of ginger is due to gingerol which is an alcohol of oleoresin and the 
aroma is due to its oil (Hasenohrl et al., 1998). Gingerol is the major 
pharmacologically active component including a cause of apoptosis (Lee and 
Surh, 1998; Lee et al., 1998) in cancer cells. The results of the present study 
reveal that the selected dosages of genistein and gingerol are not genotoxic 
per se but reduce the genotoxic damage caused by oxandrolone and 
norethandrolone in human lymphocytes in vitro. The International Agency on 
Cancer (lAC), mainly on the basis of epidemiological studies classifies 
steroidal estrogen progestin combinations among agents carcinogenic to 
humans (Group 1), progestins as possibly carcinogenic (Group 2) and 
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androgenic anabolic steroids, as probably carcinogenic (Group 2A) (Martelli et 
al., 2003). 
An increase in the frequency of chromosomal aberrations in peripheral 
blood lymphocytes is associated with an increased overall risk of cancer 
(Hagmar et al., 1994, 1998). The readily quantifiable nature of sister 
chromatid exchanges with high sensitivity for revealing toxicant-DNA 
interaction and the demonstrated ability of genotoxic chemicals to induce 
significant increase in sister chromatid exchanges in cultured cells has 
resulted in this endpoint being used as indicator of DNA damage in blood 
lymphocytes of individuals exposed to genotoxic carcinogens (Albertini et al., 
2000). The above genotoxic endpoints are well known markers of genotoxicity 
and any reduction in the frequency of these genotoxic endpoints gives us 
indication of the antigenotoxicity of a particular compound (Albertini et al., 
2000). Many products protect against xenobiotics either by inducing 
detoxifying enzymes or by inhibiting oxidative enzymes (Morse and Stoner, 
1993). 
The protective effect observed in the present study i.e. significant 
reduction in the frequency of cells with chromosomal damage and sister 
chromatid exchanges, may be due to the direct action of the compounds (i.e. 
genistein and gingerol). 
The outcome of this experiment shows that norethandrolone and 
oxandrolone have the potential to be genotoxic and cytotoxic, especially at 30 
and 40 [xM, in cultured human lymphocytes and their genotoxicity is reduced 
significantly on applying genistein and gingerol separately, at appropriate 
dosage. The evaluation of these genotoxicity tests is a useful tool for 
determining the toxic effects of potentially genotoxic chemicals, leading to 
identification of such carcinogenic agents. It is advisable to use the steroids 
studied here at their lowest effective dosage so that the risk to public health 
could be minimized. The risk of damage to human genetic material is very 
likely at higher doses of these drugs. The effectiveness of genistein and 
gingerol as antimutagenic agents is an attribute that can be effectively used in 
making anticancer drugs. 
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The result of the present study reveals that TP is genotoxic only in the 
presence of metabolic activation (S9 nnix + NADP). The first step may involve 
aromatic hydroxylation catalyzed by cytochrome p450 as in the case of other 
steroids (Fishman, 1983). Cytochrome p450 in liver S9 fractions plays an 
important role in activating promutagens to proximate and/or ultimate 
mutagens (Maron and Ames, 1983; Guengerich and Shimada, 1991). 
Testosterone in human body can be converted to both estrogen 
(aromatization) as well as dihydrotestosterone. Estrogen is the main 
metabolic for many side-effects in the human body and it has also been 
reported for genotoxicity in various in vitro and in vivo experimental models 
(Dhillon et al., 1994; Hundal et al., 1997; Joosten et al., 2004; Siddique et al., 
2005a). 
In our present study, TP was found to increase CAs and SCEs at 20 
and 40 \iM. CAs are changes in chromosome structure resulting from a break 
or an exchange of chromosomal material. Most of the CAs observed in the 
cells are lethal but there are many other aberrations that are viable and can 
cause genetic effects either somatic or inherited (Swierenga et al., 1991). 
SCE is generally a more sensitive indicator of genotoxic effects than structural 
aberrations (Tucker and Preston, 1996). There is a correlation between the 
carcinogenicity and SCE inducing ability of large number of chemicals 
(Gebhart, 1981). The ready quantifiable nature of SCEs with high sensitivity 
for revealing toxicant-DNA interaction and the demonstrated ability of 
genotoxic chemicals to induce significant increase in SCEs in cultured cells 
has resulted into this endpoint being used as an indicator of DNA damage in 
blood lymphocytes of individuals exposed to genotoxic carcinogens. The 
above genotoxic endpoints are well known markers of genotoxicity and any 
reduction in the frequency of the genotoxic endpoints gives an indication of 
the antigenotoxicity of a particular compound (Albertini et al., 2000). Increase 
of chromosomal aberration has been associated with the increase in the 
incidence of formation of various carcinomas (Hagmar et al., 1994; Hagmar et 
al., 1998). 
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Natural plant products have been reported to reduce genotoxic effect of 
steroids in various in vitro and in vivo models. The genotoxic effects of 
steroids can be reduced by the use of antioxidants and natural plant products 
(Ahmad et al., 2004; Siddique and Afzal, 2005b; Siddique et al., 2005b; 
Siddique et al., 2006b; Siddique et a!., 2007a,b,c; Beg et al., 2007; Siddique 
et al., 2008a,b). In this study, ECG reduces genotoxicity of TP in human 
lymphocytes. The reduction in genotoxic damage may be due to the 
possibility of the prevention of metabolic activation of TP by ECG. The 
selected dosage of ECG is potent enough to reduce genotoxicity. The 
concentrations studied here are higher than those of commonly used steroids. 
The higher concentration may be reached in some clinical conditions (Martelli 
et al., 2003) and this higher concentration may lead to genotoxic damage and 
may further increase the possibility of the development of various types of 
cancers (Albertini et al., 2000). ECG reduced genotoxic damage by the 
highest tested dosage thereby giving an indication of its protective role. 
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Abstract: The aim of this expenment was to find the appropriate dosage at which Testosterone Propionate (TP) 
is genotoxic enoiigh to cause significant cliromosome damage. TP was examined at 10, 20 and 40 (iM, 
respectively and found to be significantly genotoxic at 20 and 40 jiM, only in the presence of metabolic 
activation Epicatechin Gallate QJICO) proved to be an effective antioxidant by reducing genotoxic damage Tlie 
results imply a strong genotoxic effect of TP in vitro on human lymphocytes and also a relevant anligenotoxic 
role of ECO in ameliorating steroid induced genotoxicity 
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I N T R O D U C T I O N 
Synthetic anabolic steroids arc based on the principal 
male honiione lesloslerone and bind to receptors ui 
reproductive tissues, muscles and fat (Matsumoto et al, 
2008). Testosterone Propionate (TP) is a very strong 
androgenic compound having a liigh anabohc effect. 
Users of this compound gain powerfiil strength fast 
without excessive gam m body weight TP is tlie acetate 
form of trenbolone and hence its elTect lasts only for a 
short time leading to the need for frequent administration 
TP has considerable androgenic side effects both in men 
and women Athletes using this compwund often report 
headaches, nasal bleedi i^ , high blood pressure, oily skm 
with acne .uid jiartly .in eiioniioiiii increiise in aggressive 
behavior (I'ope et al., 2000, Chance et ai, 2000, 
hItp/Avww testosleronepropionate com/ Testosterone 
Propionate-profiJe html) 
The treahncnt witli andiogens has been repoited to 
render Cerebellar (Jronule ('ells less vulnerable to 
oxidative stress-induced ajx^ptosis by potentiating 
antioxidant dcfciKcs (Ahlbom et al., 1999) Androgen 
ingestion by a pregnant mother can cause vinlizaUon of a 
female fetus (Dewhiirsl and Ciordon, 1984) The only 
legitimate therapeutic mdicahons for such anabolic 
steroids are in the replacement of male sex steroids in men 
who have andiogen deficiency, e g , due to loss of both 
testes, in the treatment of certain laie fomis of aplastic 
anemia which arc or may be responsive to anabolic 
androgens and in certain countries to counteract catabolic 
slale-s, e g after major trauma (Inteniational Programme on 
Chemical Safety, 1993) The steroids have been reported 
to be genotoxic in human lymphocjrtes in vitro and 
in mouse bone-marrow cells (DhiUon et al, 1994, 
Hundal et al, 1997; Joosten et al, 2004, Siddique and 
A fziil, 2004a-c, 2005a; Siddique el al, 2005a, b, 2006a) The 
genotoxic effects of steroids can be reduced by the use of 
antioxidants and natural plant products (Ahmad at al., 
2004, Siddique and Afzal, 2005b, Siddique et al., 2005b, 
2006b, 2007a-c, 2008a, b ; Beg et al, 2007) The earlier 
studies are concerned witli tlie estrogens and synthetic 
progestins. The present study deals witli the androgen 
that is used in the treatment of various hormonal diseases 
and for boosting muscle growth in patients and also m 
body-building (LntemaUonal Programme on Chemical 
Safety, iggS) 
TP lias been shown to induce cell bans formation m 
a dose-relalied manner in Syrian Hamster Embryo (SHE) 
cells (Tsutsui et al, ) 99.5) TP does not reduce the toxic 
effect of anticancer drugs on hemopoietic pluripotent 
stem cells (Boglioloeio/ , 1982) Treatment witli I T foi a 
long duration causes development of leiomyosarcomas m 
the vas deferens or uterus of Golden Syrian hamsters 
(Hudson et al, 1998) Apart from these reports of TP 
toxicity in hamsters, TP has been reported to reduce the 
toxicity of thiamphenicol in male Sprague-Dawley rats 
(Malta et al, 2004) TP also produces a direct toxic 
effect in heart cell cultures neonatally in rat (Welder et al, 
1995). 
Such reports of TP toxicity in experiments conducted 
on hamsters, rats and mice, prompted us to test TP's toxic 
yjotential using cultured human lymphocytes in the 
I)resetice as well as absence of metabolic activation 
(using S9 mix) 
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Epicatechin gallate (ECO), a catechin, is a 
polyphenolic antioxidant plant metabolite whose largest 
source in the human diet is from various teas (including 
while tea, green tea, black tea ;ind Oolong tea) derived 
from die tea-plant Camellia sinensis (Balentine et al., 
1998) The health benefits of catechins have been studied 
extel^<^lvely in humans and in animal models Reduction in 
adieroscleroUc plaques (Cliyu et al, 2004) and m 
carcinogenesis was seen in vitro (Miftal et at, 2004) iind 
m vix'o models Epigallocatechin-3-gallafce (EQCQ), a 
related compound, is an antioxidant that helps protect tlie 
skin from UV radiation-induced damage and tumor 
formation (Katiyjir et al, 2007). Oreen tea catechins liave 
also been shown to possess antibiotic properties due to 
their role in disruplii^ a specific stage of (lie bacterial 
DNA lepLcation process (Gradisai et al., 2007) White tea 
typically contains higher level of catechins 
(httfr/Zfindarticlcs com/p/art icles/mi_mo854/is9 26/ai_ 
1118616257) 
In this sluily, we also oliseived the anlioxulanl 
activity of ECG when it was used in order to reduce 
genotoxic damage due to TP, both in tlic presence and 
absence of metabolic activation 
MATERIALS AND METHODS 
C!hctnicals and reagents: Testosterone propionate 
(Sigma-Aldrich), Epicatechin gallate (Sigma-Aldrich), 
Rl 'MI-1640 (thlx;o), Felal calf seium (Oil>co), 0 1 ml. 
Antibiotic-antimycotic mixture (Gibco), Phyto-
haema^ lu tmin -M (Gibco); Colchicine (Microlab), 
Hoechst 33258 stain (Fluka); 3 % Giemsa solution in 
phosphate buffer, pH 6 8 (Merck); 5-Bromo-2-
deoxyuridine, BrdU (Sigma-Aldrich); Dimethylsulphoxide, 
DMSO (Meick), Mitomycin C, (Meick), Cyclophos-
phamide (Sigma-Aldnch). 
Lymphocyte cutture and chromosomal aberration 
analysin: Peripheral blood cultures were done in <hiplicate 
(Carballoe/a/., 1993). Hepannizedblood (0.5 inl,) samples 
were taken from healthy female donors and were placed in 
sterile tubes containii^ 7 mL of RPMI-1640, supplemented 
with 1 5 mL of fetal calf serum and 0 1 mL of 
phytohaemaggluttmii and mcubated at 37°C for 24 li 
Testosterone propionate dissolved in dimethyl 
sulphoxide (DMSO) was added separately to different 
cultures at 10 ,20 and 40 pM DMSO (5 ^L mL "') served as 
negative control For metabolic activation experiments, 
0.5 mL of S9 mix was given with each treatment. S9 mix 
was prepared according to the standard protocol of 
Maron and Ames (1983). S9 mrx was given for 6 hours 
after which cells were collected by centrifugation and 
washed in prcwarmed media to remove the traces of S9 mix 
and drugs. Two hours before harvesting, 0 2 mL of 
colcliicine (0 2 pg mL" ' ) was added to the culture tubes 
Cells were centrifuged at 800-1 OCX) qim for 10 mm 'I'he 
supernatant was removed and 5 mL of pre-warmed (37'''C) 
0.075 M KCl hypotonic solution was added. Cells were 
resuspended and incubated at 37"C for 15 m m The 
supenialant was removed by centnfugation and 5 inL of 
fixative (methanol, glacial acetic acid, 3.1) was added. The 
fixat ivc was removed by contrifugaticxi and the procedure 
was repeated twice. Tlie slides were stained m Giemsa 
solution in phosphate buffer for 15 min. At least 300 
metijphases were analyzed for different types of 
chromosome breakage frequencies. Classification of 
aberrations was done accordi i^ to the guidelines of the 
International Piogiamme on Chemical Safety, WHO, 
Geneva, for the study of genetic defects m human 
{XJpulation (International Programme on Chemical Safety, 
1985) 
Sister chromatid exchange analysis: For SCE analysis, 
BrdU (10 pg mL~') was added at the beginning of the 
culture After 24 h, same treatments were given as for CA 
analysis. Two hours before harvesting, 0 2 ml , of 
colchicine (0.2 pg mL~') was added, followed by 
hypotonic Lieatmenl and Oxatioii and piocessing of sLdes 
(Perry and Wolff, 1974) was done as for CA analysis 
Slides were stained for 20 mm in 0 0 5 % (w/v) Hoechst 
3325X solution, rinsed wilii tap water and placed under 
a UV lamp for 90 min covered with Sorensen's buffer 
(pl l 6 8) and stained with Giemsa solution in phosphate 
buffer for 15 min. The sister chromatid exchange avere^e 
was taken from an analysis of 50 mefaphases 
Treatment o f T P with E C G : Each genotoxic dose of TP 
was treated with the appropriate dose ofECO. 2 0 a n d 
40 p M each of TP was tieated with 20, 30 and 40 p M of 
liCQ m the presence of S9 mix This was followed by (-A 
Htid S(^F, analysis as described 
Statistical analysis: Student's t-test was used for 
calculating the statistical significance in CAs and SCEs. 
The level of significarKe was tested using standard 
sLdlistical tables (Fisher and Yates, 1963). 
R E S U L T S AND DISCXTSSION 
TP was not genotoxic in the absence of metabolic 
activation (Table 1, 3). A significant increase in CAs was 
observed m the presence of metabolic activabon at 20 and 
40 p M of TP in a dose-related manner. ECG proved to be 
effective in reducing the number of abnormal ceUs with 
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Table I CA% induced by TP in cultured human tynyhocytea and (he 
antioKidit efltct of BCG on CA ftpiuency. without S9 mix 
TicBliiieiit 
(without S9 mix' 
Abnonnil 
cells 
(%+SE) 
CA» 
Gaps CTB CSB CTE DIG 
3 (1 OOtasT) 
4 (1 33±0 (S<S) 
7(2 33±0 8r) 
2 (0 67±047) 
3(100tt0 37) 
2 
3 
5 
1 
2 
18 21 15 
TP(nM) 
10 
20 
40 
Untreated 
Negative unlrol 
(DMSO, 5pLmL ') 
Positive control 34 (11 33±1 82") 
(Mitomycin C, 
OitmniL-') 
'Significant diQerence with respect to unUiealed (p<0 05), SE Standard Omir 
CTR CIroiiiatid Break, CSB Clircmobain. Break, CTR Cliraiiiatid 
Fxchange DIC Dicentric Chrotnoeome 
Table 2 CAs induced by TP m cultured hutnwi lymphocytes and the 
aniioicidant dttect o) BCG an CA tregucncv. with S9 mix 
Treatment 
(without S9 mix) 
Abnormal 
cells 
(%=U>E) Gaps CTB CSB CTb DIG 
TP(IJM) 
10 
20 
40 
ECO(|.iM) 
20 
30 
40 
EOG+TP 
20^20 
20140 
30+20 
30+40 
40+20 
4OH0 
Untreated 
Negative control 
(DMSO, 5 |JL mL-
Positive control 
(CP.OJuamL ') 
4(1 33±0 66) 
12(4 00*1 i sy 
22(7 33^50) ' 
4(1 33±0 66) 
3 (1 00±0 57) 
2(0 67+0 47) 
7(2 331.0 87') 
I7(5 67±) Vf) 
5 (1 «7±0 74') 
15(5 00±1 2ff) 
3 (1 (mo.5T) 
12(4 0O±l 13) 
3(1 00ttO57) 
3(1 OOd:0 57) 
) 
38 (1267±1 9T) 
3 
10 
13 
3 
2 
1 
5 
8 
4 
7 
2 
11 
1 
2 
19 
4 
10 2 
15 7 
3 1 
3 
1 1 
6 1 
12 5 
4 1 
10 5 
2 1 
9 3 
2 1 
2 1 
26 17 
'Sigmficanl difference with iKtpect to untrciited (jKOOl). 'S^nificanl 
diQcrcnce with respect to ixitrcaLed (p«XOS), 'Si^uficanl with leapect to TP 
(P' 0 05), SE Standard Error, CTB Chromatid Break, CSB Chromosome 
Break, CTE Oromatid Exchange, DIC Dicentric Chromaeome 
C A s i n d u c e d b y T P a t the t e s ted d o s a g e A d o s e -
dependeni decrease m number o f abnormal metaphases 
w a s observed w h e n 2 0 and 4 0 j iM o f T P w a s treated witit 
2 0 , 3 0 and 4 0 p M o f E C O The selected dosage o f E C G w a s 
n o t genotox i c i tse l f (Table 2 ) D u i i n g SCE analys is , a 
s i gmf i cant increase m S C B s w a s observed at 2 0 and 
4 0 j^ iM o f TP w h i l e H significant decrease in S C ^ s w a s 
o b s e r v e d w h e n 2 0 and 4 0 p M of TP w a s treated w i t h 2 0 , 
3 0 and 4 0 (iM o f E C O T h e s e l e c t e d dosage o f E C G itsel f 
d id not induce S C B s s ignif icant ly e n o i ^ and b e o c e w a s 
no t found g e n o t o x i c (Table 4 ) 
The result o f tlie present s tudy reveali. tliat I P is 
g e n o t o x i c only in tlie presence of metabol ic activatton 
( S 9 n u x + N A D P ) T h e firat s tep m a y invo lve aromatic 
hydroxy lahon cata lyzed b y cytochrome f)450 as m the 
Tables SCEs induced by TP n cultured human lymphocytes and Ihe 
antioiadant effect of ECO on SCE frequency, without S9 mix 
TreaUnert SCEs^Cell 
(without S9 mix) (Mean+SE) 
T P O J M ) 
10 236t0 24 
20 242+0 20 
40 Z76+0 23 
Urtreoted 1 24±010 
N^aUve control (DMBO, 5 pL mL"") 1 IStO 09 
PosiUve conlrol (Mitomycm C, 0 3 ne mL'') 10 22±1 20* 
'Significant ddference with respect to untreated (p<0 01), SE Standard Error 
Table 4 SCLc induced by TP n cuibved human trmptiocytes aud the 
anUcKidart. effect of ECG on SCE freautncv. with S9 mix 
Treatment 
(without S9 mix) 
SCEs/Cell 
(Mean±SE) 
T P ( M M ) 
10 
20 
40 
ECG()JM) 
20 
30 
40 
EOG+TP 
20+20 
20140 
30120 
30+40 
40+20 
40+40 
Untreated 
Negative conlrol PMSO, 5 UL mL"') 
I'oBiUve conlrol (CP. 0 3 ug mL~') 
256+0 22 
5 84-tO 4^ 
7 81*062^ 
1 71t033 
1 77±0 37 
1 94±045 
288±0 26° 
274+0 24' 
254+0 22" 
4 98±0 36* 
4 22±0 32 
3 98+030 
12J+010 
120±010 
11 48+1 4 ? 
•Significant difference wUh respect (o uidreated (p<001), ''Significant 
diffirence with respect to untreated (p<0 05), 'Significant with respect to TP 
^<0 05), S£ Standard Qror 
c a i e o f other steroids (F i shman, 1 9 8 3 ) Cytochrome p 4 5 0 
in l iver S 9 fractions p lays an important role m act ivatmg 
promutagens to proximate and/or ult imate m u t ^ e n s 
(Maran and A m e s , 1 9 8 3 , ( j u e n g e n c h and Shimada, 1 9 9 1 ) 
Testos terone i n h u m a n b o d y c a n b e converted to bo th 
e s t rogen (aromatizat ion) a s w e l l a s dihydrotestosterone 
E s t r o g e n is the m a m metabohte for m a n y s ide-ef fects m 
the h u m a n b o d y and it has a l s o b e e n reported tor 
g e n o t o x i c i t y m various tn vitro and m v ivo experimental 
m o d e l s ( D h i l l o n et al, 1 9 9 4 , Hundal er o j , 1 9 9 7 , 
Joosten et al, 2 0 0 4 , S iddique et al, 2 0 0 5 a ) 
Tn present study, T P w a s found to increase C A H and 
S C E s at 2 0 and 4 0 j i M C A s are changes m c h r o m o s o m e 
stnictiire resulting from a break or an exchange of 
c h r o m o s o m a l material M o s t o f the C A s o b s e r v e d m the 
ce l l s are letlial but there m a n y other aberrations that are 
v iable and c a n cause g e n e t i c ef fects either somat ic or 
inhented (Swierenga etal,!991) S C E is general ly a more 
seribilive mdicator o f g e n o t o x i c effects, tlian structural 
aberrations (Tucker and Preston, 1 9 9 6 ) There is a 
correlation be tween the carc inogenic i ty and S C E mducing 
abil ity o f large number o f chemica l s (Gebhart, 1 9 8 1 ) The 
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ready quantifiable nature of SCEs with high sensitivity for 
levealing toxicant-DNA interaction and the demonstrated 
abihty of genotoxic chemicals to induce significant 
increase in SCEs in cultured cells has resulted into this 
endpoint being used as an indicator of DNA damage in 
blood lymphocytes of individuals exposed to genotoxic 
carcinogens The above genotoxic enc^ints are well 
known markers of genotoxicity and any reduction in the 
fiequeucy of the genotoxic endpoints gives an mdicatioii 
of the antigenotoxicity of a particular compound 
(Albertini et al, 2000) Increase of chromosomal 
aberration has been associated with the mcrease m 
the mcidence of formation of various carcinomas 
(Hagmar etal.l 994,1998) 
Natural plant products have been reported to reduce 
genotoxic effect of steroids m vanous in vttro and m vivo 
models The genotoxic effects of steroids can be reduced 
by the use of antioxidants and natural plant products 
(Ahmad et al, 2004, Siddique and Afzal, 2005b, 
Siddique el al, 2005b, 2006b, 2007a-c, 2008a, b. Beg el a/, 
2007) In this stutfy, ECG reduces genotcKicity of TP m 
human lymphocytes The reduction in genotoxic damage 
may be due to the possibility of the prevention of 
metabolic activation of TP by ECG The selected dosage 
of ECG IS fxjtent enough to reduce genotoxicity The 
concentrations studied here are higher than those of 
commonly used steroids The higher concentration may 
be reached in some clmical conditions (Martelli et al, 
2003) and this higher concentration may lead to genotcKic 
damage and may further increase the possibility of the 
development of vanous types of cancers (Albertim et al, 
2000) 
CONCLUSION 
Bpicatechin gallate reduces genotoxic damage when 
used at the highest tested dosage, thereby giving a 
strong mdicaUon of its protective role m reducing the 
genotoxicity mduced by testosterone propionate 
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Antiigenotoxic Effect of Genistein and Gingerol mi Genotozicity Induced by 
Norethandrok>ne and Oxandrolfme in Cultured Human Lym^ocytes 
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Abstract: Norethandrolone and Oxandrolone were studied for their genotoxic effect on human lymphocyte 
chroraosomes using diromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) as parameters and 
subsequently Genistein and Oipgerol were used as antigenotoxic agents to ameliorate the genotoxicity mduced 
by the steroids This experiment was aimed at finding the dosage at which these two steroids are genotoxic 
enough to cause chromosome damage They were studied at 5, 10, 20, 30 and 40 jiM, respectively and were 
found to be significantly genotoxic at 30 and 40 pM Genistem and Gingerol proved to be equally effective m 
reducing genotoxic damage at appnopnale doses 1 he results suggest a stroi^ genotoxic effect of both steroids 
in vitro in human lymphocytes and also a significant antigenotoxic action of Oenistem and Gingerol against 
steroid induced genotoxic damage 
Key words: Norethandrolone, oxandrolone, genistein, gingerol, androgens, genotoxicity, chromosomal 
aberrations, sister chromatid exchanges, hitman lymphocytes 
INTRODUCTION 
Genistem is an anticarcinogemc isoflavone found m 
soybean seeds m the focm of glycosides It has been 
demonstrated that genistem has a great number of 
biological activities in animal cells mcluding weak 
estrogemc effect, inhibition of different kinases (including 
tyrosine kinase), antioxidant properties and modulation of 
cell proliferation and transformation (Muster «r a/, 1997) 
ftpidemiological and animal mode] studies have shown a 
leLiticsiship between a diet higli in sqyfoods and a gamut 
of beneficial effects with regard to health, mcluding 
reduced mcidence of breast and prostate cancers, 
cardiovascular disease and post-menopausal ailments 
(Dixon and Ferrena, 2002) Several studies suggest that 
genmtem exerts a protective effect against lipid 
peroxidation of low and lugh density lipoproteins 
(LDL and HDL) (Patel el al, 2001, FerretU et al, 2004X 
Genistem is synthesized from the flavonone nanngenm 
in plants through a ring migration reaction catalyzed by 
the cytochrome 1'450 enzyme isoflavone synthase (IFS) 
IPS genes have recently been cloned from many plant 
species and now genistem can be produced in non-
legumes through recanbinant DNA tec^mique (Dixon and 
Ferreird, 2002) 
The key constituents of Gmger (Zmgtber officinale) 
include volatile ods, oleoiesin (Gingra-ol, sbogaol), phenol 
(Gingerol, zingerone), vitamins and mmerals Ginger has 
medicinal purposes (Huang et al, 1990) It has 
carminative, diaphoretic and antispasmodic properties, 
reduces clotting, cholesterol and Uood pressure, is anti-
inflammatory, helpful in nausea and mdigestion 
Naturally occurring anabolic steroids are synthesized 
in the testis, ovaiy and adrenal gland from cholesterol via 
pr^neoolone Synthetic anabohc steroids are based on 
the principal male hormone testosterone (Haynes and 
Murad, 1985) They bmd to receptors in reproductive 
tii«ue, muscles and fat (Mooradian el al, 1987) 
Norethandrolone and Oxandrolone are oral anabolic-
androgemc steroids (AAS), synthesized and approved 
under the brand names Nilevar and Anavar, respechvely 
They have moderate progestagemc activity and share 
liver toKicily issues common lo 17-alkylated steroids 
Acute overdosage can produce nausea and 
gastrouitestinal upset Chrome use of Norethandrolone 
can lead to excessive androgens menstrual irregularities 
and vinlization in women and impotence, premature 
cardiovascular disease and prostabc hypertrofiiy m men 
(Intematioial Programme on Chemical Safety, 1993) 
Precocious prostatic cancer has been described after 
long term anabolic steroid abuse (Roberts and Essenhigh, 
1986) Cases where hepatic cancers have been associated 
with anabolic steroid abuse have been reported 
(Overly et aL, 1984) Also, androgen ingestion by a 
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pregnant mother can cause virilization of a female fetus 
(Dewhurat and Gordon, 1984). Oxandrolone is used in the 
treatment of anemia and hereditary angioedema, which 
causes episodes of swelling of the face, extremities, 
genitals, bowel wall and throat (Gannon, 1994) and also 
prescribed for a number of medical disorders causing 
involuntary weight loss, in order to promote muscle 
regrowth and in treating cases of osteoporosis. The only 
legitimate therapeutic indications for such anabolic 
steroids are in the replacement of male sex steroids in men 
who have androgen deficiency, e.g., due to loss of both 
testes, in the treatment of certain rare forms of aplastic 
anemia which are or may be responsive to anabolic 
androgens and in certain countries to counteract catabolic 
states, e.g., after major trauma (Xnternational Prognnnine 
un Chemical Safely, 1993). The steroids have been 
reported to be genotoxic in human lymphocytes in vitro 
and in mouse bone-marrow cells (Dhillon et al., 1994; 
Hundal et al., 1997; Joosten et at., 2004, Siddique and 
Afzal, 2004a, b, c; Siddique and Afzal, 2005a, 
Siddique etal., 2005a,b, 20O6ia). The genotoxic effects of 
steroids can be reduced by the use of antioxidanls and 
natural plant products (Ahmad et al., 2004; Siddique and 
Afzal, 2005b; Siddique et al., 2005b, 2006b, 2007a, b, c; 
Beg et al, 2007; Siddique et al., 2008a, b). The above 
studies are concerned widi the estrogens and synthetic 
progestins. The present study deals with the androgens 
that are used in the treatment of various hormonal 
diseases and for boosting muscle growth in patients and 
also in boc^-building (International Programme on 
Chemical Safely. 1993). 
The use of these two steroids ty humans and their 
ability to act as genotoxic agents, as suggested by earlier 
studies was an ample reason for us to examine their 
genotoxic potential using cultured human lymphocytes. 
In this study, we pirimarily analyse the antigenotoxic 
effect of Genistein and Gingerol separately on the 
frequency of CAs and SCEs induced by Norethandrolone 
and Oxandrolone respectively, in vitro in human 
lymphoc)rt;es. 
MATERIALS AND METHODS 
Time and place of study: The study was conducted horn 
April-September. 2007, in the Himian Genetics and 
Toxicology Laboratory, Department of Zoology, AMU, 
Aligarh (UP), hidia. 
Colchicine (Microlab); Hoechst 33258 stain (Fluka); 
3% Giemsa solution in phosphate buffer, pH 6.8 
(Merck); 5-BTOino-2-deaxyuridine. BrdU (Sigma); 
Dimethylsulphoxide, DMSO (Merck); Mitomycin C 
(Merck). 
Lymphocyte cuMure and chromosomal aberration 
analynis: Peripheral blood cultures were done in duplicate 
(Caifoallo et al, 1993). Heparinized blood (0.5 mL) samples 
were taken from healthy female doncxs and were placed in 
sterile tubes containing 7 mL of RPMI-1640, supplemoited 
with 1.5 ttiL of fetal calf serum and 0.1 mL of 
phytohaemagghitinin and incubated at 37''C for 24 h. 
Norethandrolone and Oxandrolone, both dissolved in 
dimethyl sulf^oxidc (DMSO), were added scparatoly to 
different cultures at 5, 10, 20, 30 and 40 pM. DMSO 
(5 pi mL~') served as negative control. 
Two hours before harvestir^, 0.2 mL of colchicine 
(0.2 pg mL~') was added to the culture tubes. CeUs were 
centrifugod at 80O-1000 rpm for 10 min. The supernatant 
was removed and 5 mL of pre-warmed(37°C) 0.075 M KCl 
hypotmiic solution was added Cells were resuspended 
and incubated at 37°C for 15 min. The supernatant was 
removed by centnfugation and 5 mL of fixabve (methanol: 
glacial acetic acid, 3:1) was added. The fixative was 
removed by centrifv^ation and the procedure was 
repeated twice. The slides were stained in Giemsa solution 
in pho^^atB buffer for 15 min. At least 300 metaphases 
were analyzed fijr different types of chromosome t>reakage 
frequencies. Classificatiwi of aberrations was done 
according to the guideliiies of tiie International 
Programme on Chonical Safety (1985) WHO, Geneva, for 
the study of genetic defects in human population 
Sister chromatid exchange analysis: For SCE analysis, 
BrdU (10 pg mL~') was added at the beginning of the 
culture. After 24 h, same treatments were given as for CA 
analysis. Two hours before harvesting, 0.2 mL of 
colchicine (0.2 jig mL~') was added, followed by 
hypotonic treatment and fixation and processing of slides 
(Perry and Wolft 1974) was done as for CA analysis. 
Slides were stained for 20 min in 0.05% (w/v) Hoechst 
33258 solution, rinsed with tap water and placed under a 
UV lamp for 90 min covered with Sorensen's buffer 
(pH 6.8) and stained with Giemsa solution in phosphate 
buffer for 15 min. The sister chromatid exchange averse 
was taken from an analysis of SO metaphases. 
Chemicals and regents: Norethandrolone; Oxandrolone; 
Genistein (Sigma); Gii^enal (Sigma); RPMI-1640 (Gibco), 
Fetal calf serum (Gibco); 0.1 mL Antibiotic-antimycotic 
mixture (Gibco), Phytohaemagglutinin-M (Gibco); 
Statistical analysis: Student's t-test was used for 
calculating the statistical significance in CAs and SCEs. 
The level of significaiKe was tested using standard 
statistical tables (Fisher and Yates, 1963). 
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RESULTS 
Both Genistein and Gir^erol proved to be equally 
effective in red\]cing the nuinbeT of abnormal cells with 
CAs induced by Norethandrolooe and Qxandrolone at all 
their tested doses. A significant increase in CAs was 
observed at 30 and 40 (iM of bc*h norethandrolone and 
oxandrolonc (Table 1, 2). The dose-dependent increase in 
CAs was not much from 30 to 40 fiM. 
A dose-dependent decrease in number of abnormal 
metaphases was observed when the genotoxic doses 
of norethandrolone were treated with 30 and 40 MM of 
Ti cjUiients 
Norettiaidrolane (|JM) 
5 
10 
20 
JO 
40 
Oenistetn ()iM) 
30 
40 
Cr«nistdn -^ Nw e«ll«K> ulone 
30 + 30 
30 + 40 
40+30 
40 + 40 
<3ingen>l(]M) 
20 
30 
GingiTol 1 NctcUundrolonc 
20+30 
20 + 40 
30 + 30 
30 + 40 
tJnfrartcd 
Negative control (DMSO, 5 ni mL"') 
Positive cot<iDl (Mitomvcm C, 0,3 uamL"'! 
No. of ibncnnal 
ccDi (%tSB) 
7a33i<187) 
8(Z67±0.93) 
10(3 33±104) 
21 (7 tXMATf 
27 (9 OOtl 6Sf 
4 (1 33±0.6«) 
5(1 67±a74) 
M(i00ii.26r 
21 (7 00±1 47)F 
11 (3 67±1 09f 
17(3 67±134y 
3(l00±0.5r) 
4(1 33±0.66) 
13(4 33*1 \Sf 
I8(6 00±1.37)r 
9(3 00tt0 98y 
U (3 67±1.09f) 
3(1.00*0.37) 
3(1.00±0.5^ 
60f20 0Ot2.3n 
Total CAi 
Gws 
2 
3 
4 
8 
11 
1 
2 
3 
8 
4 
6 
1 
2 
5 
6 
3 
4 
2 
1 
28 
CTB 
4 
5 
6 
13 
18 
2 
3 
9 
13 
7 
11 
2 
3 
8 
10 
5 
7 
2 
2 
45 
CSB 
3 
3 
3 
7 
6 
2 
2 
6 
8 
4 
6 
1 
1 
5 
8 
4 
4 
1 
1 
20 
CTE 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
. 
-
4 
Die 
-
-
-
-
• 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2 
•Significant cSflTcnncc with raped to unlrtaled (i?<0 05X 'Signtfiont di^raice with raipect to untreated (p<0 01), 'Significant with respect to Nordhandrolanc 
(p<0 05X SE- Standvd Bror. CTB- diromilid Break. CSB: Cliromoaoroe Bteak. CTE: Chromatid Exchange, DIG- Dicentric Ctrcmosome 
Table 2: Amdjorative action of aeiiiatein and gaiggol on CAi induced by OxanAxJone fa cultiaed hunw lyimhocvtes 
Total CAs 
Treatments 
Oxandrokne CM) 
5 
10 
20 
30 
40 
OaiBtcin (jiM) 
30 
40 
Oenwtein + Cbcandrnlone 
30 1 30 
30+40 
40 + 30 
40 +40 
OingemlOiM) 
20 
30 
Oingcrol + Oxandrnlflne 
20 + 30 
20 + 40 
30 + 30 
30+40 
Untreated 
Negative control (DMSO, SplniL-') 
Positive coirirol (Mitomvcm C. 0 3 uaniL^') 
'SignifKintdifrcrcnce with retpect to untreated (iKO 01), 
ceDs (%i:SE) 
5(1 67±0 74) 
7 (233±a87) 
10(3.33*1.04) 
15 (3 0011 2Sf 
19(&33±1.4I)t' 
3 0 Oftt0 57) 
4 (1.33^066) 
10 (3 33±1 My 
14 (4 67*1 liy 
7 ( 2 3 3 * 0 8 ^ 
l l ( 3 67±109y 
2(0 67t047) 
3 (1 00*0.37) 
8(287±0.93)F 
12(4.00il.l3)f 
6 (ZOO+0.81]r 
9C3 0(»i098)' 
3 0 00*0.37) 
3(1 00*0 S'O 
48 O6L0ft+il2>' 
Gaps 
3 
3 
4 
7 
9 
1 
2 
3 
4 
2 
3 
1 
1 
3 
5 
2 
2 
1 
1 
22 
''Signifkint difnrence vnh respect to unfeeated (p 
CTB 
4 
4 
6 
10 
15 
2 
3 
6 
9 
3 
8 
1 
2 
6 
10 
4 
6 
2 
2 
38 
<0.03), 'Sign 
CSB 
1 
3 
4 
5 
4 
1 
1 
4 
5 
2 
3 
1 
1 
2 
2 
2 
3 
] 
1 
10 
illcatit With re 
CTE Die 
-
-
-
-
. 
. 
-
_ 
. 
. 
. 
-
, 
. 
. 
_ 
. 
_ 
. 
5 1 
•pect to Oxindrolcne 
<ji<0 ft5), SE Slindird a™-. CTB Oranatid Break, CSR- Onmownte Break, CTR Oiranaltd Exchw^e. DIC nicnilnc rhromosomc 
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Tables: Amdiontive action of gpii<tein andgitiBcrol an SCEi induced by 
Ncrtthani^olone in cultured human lymphocytea 
Treatments 
SOEg/Cdl 
(MearetSE) 
Norelhaxirolone (pM) 
3 
10 
20 
30 
40 
Genistein (^ iM) 
W 
40 
Genistein + Norethandrolone 
30 + 30 
30 + 40 
40 + 30 
40 + 40 
Oiiigerol OiM) 
20 
30 
OiiigCTot + N«icthandn>laiie 
20 + 30 
20 + 40 
30 + 30 
30 + 40 
Untreated 
Ncgslive control (DMSO, 5 pi mL"') 
Positive control rMitomvcin C 0.3 iismL'') 
0.7<M:0.35 
1.07i0.58 
1.33±ft64 
4.8St\.3ff 
i.9&tl.5i-
1.3SJ«.67 
1.3»t«.6S 
3.22±l.ir 
4.12±1.27 
3.01±103' 
3.52±).ir 
1.10±0.37 
1.2810.62 
3a2±l 14' 
3.78+1.2ff 
2.92±1.0ff 
3.22+1.2r 
l.OfttO.56 
1.3ba66 
i3.2i+2.or 
'Sij^ificanl difference with ic«|>ect to untreated (p<0.01), SignHicant 
diflierence with respect to untreated (p<0.OS), *Si0iificB<. with reqiett to 
Norethandrolone (p<0.05), SE: Standard Btror 
Table 4: Amdiontive action of genistein and gmgrrol on SCEi induced by 
Oxandrplane in cultured human lymphocytes 
Treatments 
Oxandrolone (f>M) 
5 
10 
20 
30 
40 
Genistein (|iM) 
30 
40 
Genistein + Qxanikolone 
30 + 30 
30+ 40 
40 + 30 
40 + 40 
Gingerol (JJM) 
20 
30 
Gingerol + (-)xandrolcne 
20 + 30 
20 + 40 
30 + 30 
30 + 40 
Untreated 
Negiitive coirirol (DMSO. 5>JmL ') 
Positive control (Mitotnvcin C 0.3 UiiinL"'') 
SCEs/Cell 
(MeamiSE) 
a75±0.32 
10»i0.56 
1.26M).«0 
ASfetLiaf" 
5.22+1.24' 
1.37±0.«8 
1.42±0.® 
3.32l:1.10f 
4.02+1.16' 
3 04±1.06' 
3.64*1.12' 
1.12*0.36 
1.32±0.5« 
3.02±1.0ff 
3.7>tl.25= 
X78±0.9» 
3.34il.02' 
1.0010.56 
I.33i0 66 
14.26tl.96' 
•Si^ficaiA difference with leqiect to unbealed (jxttOl), 'Significant 
dina-cnce with rcaptcl to untreated <j><a05), "SigpiGcant wth reaped to 
OxandiDlone (p<O.OS), SE: Standard Eiror 
genistein and 20 and 30 jiM of gingerol (Table 1). The 
selected dosage of genistein and gingerol was not 
genotcixic itself (Table 1, 2). Similar dose-dependent 
decrease in number of abnormal metapliascs was 
observed when the genotoxic cioses i.e., 30 and 40 ;iM 
of oxandrolone was treated with 30 and 40 jiM of 
genistein and 20 and 30 pM of gingerol, respectively 
(Table 2). 
For sister chromatid exchange analysis, a aigniflcaiit 
increase in SCEs/cell was observed at 30 and 40 yM of 
norethandrolone and oxandrolone, respectively 
(Table 3, 4). A significant decrease in SCEs/cell was 
observed when 30 and 40 jiM of norethandrolone was 
treated with 30 and 40 jiM of genistein and 20 arxi 30 )iM 
of gingerol (Table 3). Similartrend was observed when 
30 and 40 pM of oxandrolone was treated with 30 and 
40 nM of genistein and 20 and 30 |xM of gingerol, 
respectively (Table 4). The selected dos^e of gingerol 
and genistein did not induce SCEs/cell signiflcantly as 
compared to the untreated (Table 3, 4). 
DISCUSSION 
Crenistein is particularly effective in quenching &«€ 
radicals produced by toxic agents and protects cells 
against oxidative damage especially with respect to ONA 
(Foti et al., 2005; Lee et cd., 2000). It is a common 
precursor in the biosynthesis of antimicrobial 
f^ytoakxins and phytoanticipins in legumes and an 
impcrtant nutraceutical molecule. It is also capable of 
inhibiting lipoprotein oxidation in vitro and supfiressing 
formation of plasma lipid oxidation ptxsducts in vivo. 
Extracts of Ginger (inclviding Qii^erol) have antioxidant 
activity through scavenging of si^ieraxide and hydroxy! 
radicals and by inhibiting lipid peitixidation (Kikuzaki and 
Nakatani, 1993). It is also antibacterial, antifiingal and 
used for common cold (Bode et al., 2001). The pungency 
of Qinger is due to Gingerol which is an alcohol of 
oleoresin and the aroma is due to its oil (Hasendhrl et al., 
1998). Gingerol is the major pharmacologically active 
component irxlucing apoptosis (Lee and Surfa, 1998; 
Lee et al., 1998) in cancer cells. The results of the present 
study reveal that the selected dosages of genistein and 
gingerol are not genotoxic per se but reduced the 
genotoxic dam^e caused by oxandrolone and 
norethandrolone in human lymphocytes in vitro. The 
International Agency on Cancer (lAC), mainly on the 
basis of epidemiological studies classifies steroidal 
estrogens and estrogen progestin combinations among 
agents carcinogenic to humans (Group 1), progestins as 
possibly carcinogenic (Group 2) and androgenic anabolic 
steroids, as probably carcinogenic (Grot^ 2A) 
(Martelli etal, 2003). 
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An increase in the frequency of chromosomal 
aberrations in pcnphcral Wood lymphocytes is associated 
with an increased overall nsk erf cancer (Hagmai et al, 
1 994, 1998) The readily quantifiable nature of sister 
chromaUd exchanges with high sensitivity for revealing 
toxicant-DNA interaction and Uie deinoiistialed abilify of 
genotoxic chemicals to induce sigmficant increase in 
sister chromatid exchanges m cultured cells has resulted 
in this enc^KMit being used as indicaloi of DNA damage 
in blood lymphocytes of individuab exposed to genotoxic 
carcmogens (Albertini etal, 2000) The above genotoxic 
enc^oints are well known maiicera of genotoxicity and any 
reduction m ihe ftequency of these genotoxic endpoints 
gives us mdication of tlie antigentoxicity of a particular 
compouixi (Albertini et al, 2000) Many plant products 
protect against xenobiotics eitlier by mducuig detoxitying 
en^TTies or by inhibiting oxidative enzymes (Morae and 
Sloncr, 1993) 
T he protective effect observed in the present study 
1 e , significant reduction in the frequency of ceilb with 
chromosomal damage and sister chromatid exchanges may 
be due to the direct action of the compounds (i c , 
CieniMein andGmgerol) 
I he outcome of this expenmeni show^ that 
NorelhaiMtolone and OxaiKlroloiie liave llie poterilia] to 
be genotoxic and cytotoxic, especially at 30 and 40 pM, in 
cultured human lymphocytes and their genotoxicity is 
reduced significantly MI applying Gemstein and Guigerol 
separately, at appropriate dosage The evaluation of these 
genotoxicity tests is a useful tool for determining the toxic 
effects of potentially genotoxic chemicals, leading to 
identification of such carcinogenic agents It is advisable 
to use the steroids studied here at their lowest effective 
dosage so that the nsk to public health could be 
mmuniixxl The nsk of damage to human genetic material 
IS very likely at higher doses of these dnigs 1 he 
effectiveness of Genislein and Gingerol as antimutagenic 
dgenls IS an attribute that can lie effectively ibed in 
making anticancer diygs 
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Abstract 
Genistein, an antioxidant, has earlier been shown to have a protective action against 
genotoxicity induced by certain drugs. In order to investigate the antimutagenic prop-
erty of genistein toxicity in the form of chromosomal aberration (CA) and sister chro-
matid exchanges (SCE) were induced by known mutagens-Cyclophosphamide (CP) and 
Methyl methanesulphonate (MMS) - in cultured human lymphocytes, in the presence as 
well as absence of metabolic activation, respectively; Genistein was used at two different 
doses, and was found to reduce substantially CAs and SCEs, thus providing effective 
protection against CP- and MMS-induced genotoxicity. 
Introduction 
Genistein (4',5,7-triltydxDxyisoflavone) is an anticarcino-
gcnic isoflavonc found in soybean seeds in the form of 
glycosides. It has been demonstrated that genistein has a 
great number of biological activities in animal cells in-
cluding weak estrogenic effect, inhibition of dilTeienl 
kinases (including tyrosine kinase), antioxidant proper-
ties, and modulation of oeU proliferation and transforma-
tion [1]. Genistein is particularly eflective in quenching 
free radicals produced by toxic agents and protects cells 
against oxidative damage especially with respect to DNA 
|2,3|. It is a common precursor in the biosynthesis of an-
timicrobial phytoalexins and phytoanticipins in legumes, 
and an important nutraceutical molecule. Epidemiological 
and animal model studies have shown a relationship be-
tween a diet high in soya-foods with reduced incidence of 
breast and prostate cancers, cardiovascular disease and 
post-menopausal ailments [4]. It is also capable of inhibit-
ing lipoprotein oxidation in vitro and suppressing forma-
tion of plasma lipid oxidation products in vivo. Several 
studies suggest that genistein exerts a protective effect 
against lipid peroxidation of low and high density lipo-
proteins (LDL and HDL) [5,6]. Genistein is synthesized 
from the flavonone naringenin in plants through a ring 
migration reaction catalyzed by the cytochrome P450 en-
zyme isoflavone synthase (IFS). IFS genes have recently 
been cloned from many plant species, and now genistein 
can be produced in non-legumes through recombinant 
DNA technique [4]. In this study, we examined the anti-
genotoxic effect of genistein on the frequency of CAs and 
SCEs induced by methyl methanesulphonate (in the ab-
sence of metabolic activation) and cyclophosphamide (in 
the presence of metabolic activation) in vitro in human 
lymphocytes. 
Materials and Methods 
Chemicals and reagents: 
Genistein (Sigma); RPMI-1640 (Gibco); fetal calf serum 
(Gibco); 0.1 ml antibiotic-antimycotic mixture (Gibco); 
phytohaemagglutinin-M (Gibco); Dimethylsulphoxide 
(DMSO; Merck); colchicine (Microlab); Hoechst 33258 
stain (Fluka); 3% Gicmsa solution in phosphate buffer 
(pH 6.8; Merck); 5-bromo-2-deoxyuridine (BrdU; Sigma); 
cyclophosphamide; methyl; methanesulphonate (Sigma) 
and for S9 mix preparation, Swiss albino healthy rats 
(Wistar strain) and 0.1% phenobarbital were used. 
Lymphocyte Culture and Chromosomal Aberration 
Analysis 
Peripheral blood cultures were done in duplicate [7]. 
Heparinized blood (0.5 ml) samples were taken from 
This paper was presented at "National Seminar solid waste management: solutions and concerns & XIX Aimual Confer-
ence of National Environmental Science Academy (NESA), New Delhi", September 16-18, 2006, organized by Centre 
for Environment and Vocational Studies, Panjab University, Chandigarh, India 
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iicailliy female donors, and were placed in sterile tubes 
containing 7 ml of RPMI-1640, supplemented with 1.5 rr' 
of fetal calf serum and 0.1 ml of phytohaemag^luiinin, 
and incubated at 37°C for 24 hours. Cyclophosphamide 
(.0.16 |J.g/ml) and methyl methanesulphonate (60 pM) [8], 
both dissolved in distilled water, were added separately to 
different cultures. Genistein (dissolved in DMSO) was 
added to each of the cultures in two different doses (25 
and 40 |AM, respectively) [9] and kept for another 48 
hours. DMSO (5 (il/ml) served as negative control. For 
metabolic activation experiments, liver S9 fraction was 
freshly prepared as per standard procedure [10]. 0.5 ml of 
S9 mix was added along with each treatment after 24 
hours of the commencement of culture. Negative control 
was also given 0.5 ml of S9 mix. 
Two hours before harvesting, 0.2 ml of colchicine (0.2 
(ig/ml) was added to the culture tubes. Cells were centri-
fuged at 800-1000 rpm for 10 min. The supernatant was 
removed and 5 ml of pre-warmed (37°C) 0.075 M KCl 
hypotonic solution was added. Cells were resuspended 
and incubated at 37°C for 15 min. The supernatant was 
removed by centrifugation and 5 ml of fixative (methanol: 
glacial acetic acid, 3:1) was added. The fixative was re-
moved by centrifugation and the procedure was repeated 
twice. Slides were stained in Giemsa solution in phos-
phate buffer for 15 min. At least 300 metaphases were 
analyzed for different types of chromosome breakage fre-
quencies. Classification of aberrations was done accord-
ing to the recommendation of EHC 46 for Environmental 
Monitoring of Human Population [ 11]. 
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Sister Chromatid Exchange Anafysis 
For SCE analysis, BrdU (10 (xg/ml) was added at the be-
giiuiing of the culture. Afb:r 24 hours, same treatments 
were given as for CA analysis. Two hours before harvest-
ing, 0.2 ml of colchicine (0.2 ^g/ml) was added, followed 
by hypotonic treatment, fixation and processing of slides 
[12] were done as for CA analysis. Slides were stained for 
20 min in 0.05% (w/v) Hocchst 33258 solution, rinsed 
with tap water and placed under a UV lamp for 90 min 
covered with Sorensen's buffer ^ H 6.8) and stained with 
Giemsa solution in phosphate buffer for 15 min. The sis-
ter chromatid exchange average was taken from an analy-
sis of 50 metaphases. 
Statistical A nalysis: 
Student's 't' test was used for calculating the statistical 
significance in CAs and SCF.s. The level of significance 
was tested from standard statistical table of Fisher and 
Yates [13]. 
Results 
A similar pattern was observed in CA induction study 
both in the absence and presence of metabolic activation. 
This was true for both MMS and CP induced CAs and the 
dose-dependent decrease in CAs on treatment with gen-
istein (Tables 1, 2). Overall, the number of abnormal cells 
got lowered. 
Table 1: Chromosomal aberrations in human lymphocytes when treated with MMS and 
two different doses of genistein in the absence ofS9 mix. 
Treatment Cells Abnormal cells 
scored (Mean%±St«ndard Error) 
Total chromosomal aberrations 
Gaps CTB CSB CTE DIG 
Total breaks 
wlltauut gaps 
MMS 
60 nM 
Genistein 
25 nM 
40 nM 
Genistein (M.M) + 
M M S ( H M ) 
25+60 
40 + 60 
Controls 
Untreated 
Negative (DMSO, 5 
^l/ml) 
300 
300 
300 
300 
300 
300 
300 
25(8.3311.595") 
4 (1.33 ±0.661) 
3 (1.00 ±0.574) 
17 (5.67 ±1.335*') 
15(5.00±1.258S 
3 (1.00 ±0.574) 
4 (1.33 ±0.661) 
10 
2 
1 
6 
4 
1 
2 
3 
2 
8 
5 
2 
3 
1 
1 
2 
1 
1 
1 
16(5.33) 
4(1.33) 
4(1.33) 
11 (3.67) 
6 (2.00) 
3(1.00) 
4(1.33) 
"Significant difference with respect to control (P<0.01)."Significant difference with respect to MMS (P<0.01).CTB: 
Chromatid break, CSB: Chromosome break, CTE: Chromatid exchange, DIC: Dicentric chromosome, MMS: Methyl 
methanesulphonate. 
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Table 2: Chromosonml aberrations in human lymphocytes when treated with CP and two different doses ofgenistein 
in the presence ofS9 mix. 
Treatment CeUs Abnormal celk Total chromosomal aberrations Total breaks 
scored (Mean%± Standard Error) Gaps CTB CSB CTE DIC without gaps 
CP 
0 16 ^g/ml 
Genistem 
25 ^M 
40 ^M 
Gerastein 
(^g/ml) 
25 + 0 16 
40 + 0 16 
Controls 
Untreated 
(HM)+CP 
Negative (DMSO, 5 
Hi/ml) 
300 
300 
300 
300 
300 
300 
300 
32 (10 67 ±1.782") 
2 (0 .67+0 .471) 
3 ( 1 . 0 0 + 0 574) 
23 (7.67 ±1.536*^ 
17 (5.67 ±1.335*^ 
4 ( 1 3 3 + 0 6 6 1 ) 
7 (2 .33+0 .871) 
11 
4 
3 
6 
5 
3 
2 
13 
5 
6 
8 
6 
4 
3 
5 
1 
2 
2 
1 
2 
1 
22 (7 33) 
6 (2 00) 
9 (3 00) 
10 (3 33) 
7 (2 33) 
6 (2 00) 
4(1 33) 
"Significant difference with respect to control (P<0.01), Significant difference with respect to CP (P<0.01) 
CTB. Chromatid break, CSB: Chromosome break, CTE: Chromatid exchange, DIC: Dicentric chromosome, 
CP. Cyclophosphamide 
Table 3: Effect ofgenistein on SCEs induced by MMS and CP, respectively, in cultured human lymphocytes. 
Treatment 
(Without S9 Mix) 
MMS 
60 nM 
Genistein 
25 nM 
40 ^M 
CeUs 
Scored 
50 
50 
50 
Gerastein (nM) + 
MMS(^M) 
25 + 60 
40 + 60 
Controls 
Untreated 
Negative 
(DMSO, 5|il/nil) 
50 
50 
50 
50 
SCEs/Cell 
(MeaoiStandanl Error) 
19.14 ±0 .91 ' ' 
2.45 ±0.29" 
2.89 ±0.35° 
12 10 ± 0 78" 
10.12 ±0.67" 
2 92 ± 0 36 
2 57 ±0.35 
Treatment 
(With S9 Mix) 
CP 
0.16Hg/ml 
Genistein 
25 nM 
40 nM 
Genistein (tiM) + 
CP(^g/nil) 
25 + 60 
40 + 60 
Controls 
Untreated 
Negative 
(DMSO, 5nl/ml) 
CeUs 
Scored 
50 
50 
50 
50 
50 
50 
50 
SCEs/Cell 
(Mean±Standard 
Error) 
13.21 ±058 ' ' 
4 13 ± 0 34' 
4.75 ±0 .36 ' 
9 34 ± 0 48 ' 
7.62 ± 0 37° 
2 36 ± 0 21 
2 1 5 ± 0 19 
"Significant difference with respect to MMS; MMS: Methyl methanesulphonate, CP: Cyclophosphamide 
''Significant difference with respect to control. "Significant difference with respect to CP, 
Student's 't' test (P < 0.05). 
In the case of SCE analysis, a similar result was obtained 
Both MMS and CP showed a substantial increase m SCE 
Dose-dependent increase in SCE was observed when only 
genistem was used for treatment Significant decrease m 
SCE was noticed when genistein was used against MMS 
and CP, respectively (Table 3) 
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Discussion 
Both neoplastic and mutagenic propwrties have been ob-
sened m MMS which is a monofunctional alkylating 
agent It alkylates DNA at the N-7 position of guanine 
and the N-3 position of adenine All these changes may 
give nse to abnormal base pairing at DNA replication [14, 
15] The production of methylguanosine lesions is attrib-
uted to the SCE end point, the lesions being related to 
tumor formation [16] SCE induction by MMS has been 
studied in earlier experiments with human lymphocytes 
showing positive results [17,18] CP is also an alkylating 
agent and after metabolic activation it produces active 
mutagemc metabolic phospharamide mustard [19] It re-
acts with electron-nch area of susceptible molecules such 
as DNA and proteins [20] 
In this study, genistem is observed to lower the CAs and 
SCEs in MMS and CP- induced genotoxicity, in the abse-
nce and presence of S9 mix in culture, respectively Geni-
stein may behave as free radical scavenger and hence, 
might react with metabolites which are carcinogenic be-
fore they are able to inflict DNA damage Inhibition of 
multiplication of neoplasbc cells, includmg those in 
breasts, has been reported for genistein [21] 
1 he results obtained m this study with genistein, a flavor-
noid, support the work done until now on natural products 
(especially genistein) with respect to their chemopreven-
tive potential to reduce the genotoxicity induced by carci-
nogenic compounds fherefore, genistein and other simi-
lar phytochcmicals may be utilised commercially for pha-
rmaceutical research as a model for chemopreventive 
drugs 
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ABSTRACT 
Stanozolol and trenbolone, commonly used as performance enhancing and bodybuilding drugs, were studied 
for their genotoxic effect on human lymphocyte chromosomes using chromosomal aberrations (CAs) and sister 
chromatid exchanges (SCEs) as parameters, both in the presence and absence of metabolic activation (S9 mix). 
This experiment was aimed at finding the dosage at which these two steroids are genotoxic enough to cause 
chromosome damage. They were studied at 1, 10, 20, 40, 60 mM respectively, and were found to be similarly 
genotoxic at 40 and 60 mM, in the presence as well as absence of S9 mix. The results suggest a strong 
genotoxic effect of both steroids in vitro in human lymphocytes. 
Keywords: Stanozolol, Trenbolone, Androgens, Genotoxicity, Chromosomal aberrations. Sister chromatid 
exchanges. Human lymphocytes. 
Introduction 
Naturally occurring anabolic steroids are 
synthesized in the testis, ovary and adrenal gland 
from cholesterol via pregnenolone. Anabolic steroids 
bind to specific receptors present especially in 
reproductive tissue, muscle and fat[16]. Stanozolol is 
a synthetic androgenic anabolic steroid, similar to the 
naturally occurring androgen testosterone. Jt is used 
in the treatment of anemia and hereditary 
angioedema, which causes episodes of swelling of 
the face, extremities, genitals, bowel wall and 
throat[71. Stanozolol may decrease the frequency of 
these attacks. It is one of the anabolic steroids 
commonly used by athletes and bodybuilders, 
although there is no clear evidence that anabolic 
steroids enhance overall athletic pertbrmance[5]. 
Like stanozolol, trenbolone is also a synthetic 
steroid, usually used by veterinarians on livestock as 
a growth promotant in animal husbandry[19]. 
To increase its effective half-life, trenbolone is 
not used in an unrefined form, but is rather 
administered as trenbolone acetate or trenbolone 
enanthate. Trenbolone is then produced as a 
metabolite by the reaction of these compounds 
with androgen receptor. No trenbolone compounds 
have been approved by the Food and Drug 
Administration, USA, for human use, due to a 
lack of clinical applications and considerable 
negative side effects. However, bodybuilders use 
the drug illegally to increase body mass and strength 
more effectively than by weight training alone. 
The extensive use of these two steroids, legally 
and illegally, by humans and their ability to act as 
genotoxic agents, as suggested by earlier studies 
using mammalian systems, was a good enough 
reason for us to investigate their genotoxic potential 
using cultured human lymphocytes. 
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Mater ia l s and me thods 
Chemicals and reagenl.\ 
Stanozolol (Sigma); Trenbolone (Sigma); RPMl-
1640 (Qibco); Fetal calf serum (Gibco); 0.1 ml 
A n t i b i o t i c - a n t i m y c o t i c m i x t u r e ( G i b c o ) ; 
P h y t o h a e m a g g l u t i n i n - M ( G i b c o ) ; C o l c h i c i n e 
(Microlab); Hoechst 33258 stain (Fluka); 3 % 
Giemsa solution in phosphate buffer, pH 6.8 
(Merck); 5-Bromo-2-deoxyuridine, BrdU (Sigma); 
Dimethylsulphoxide, DMSO (Merck); Mitomycin C 
(Merck); Cyclophosphamide, CP (Sigma). For S9 mix 
preparation, Swiss albino healthy rats (Wistar strain) 
and 0 . 1 % Phenobarbital were used. 
Lymphocyte culture and chromosomal aberration 
analysis 
Peripheral blood cultures were done in 
duplicate[3]. Ileparinized blood (0.5 ml) samples 
were taken from healthy female donors, and were 
placed in sterile tubes containing 7 ml of RPMI-
1640, supplemented with 1.5 ml of fetal calf serum 
and 0.1 ml of phytohaemagglutinin, and incubated at 
37"C for 24 hours. Stanozolol and trenbolone, both 
dissolved in dimethyl sulphoxide (DMSO) , were 
added separately to different cultures at the doses of 
1, 10, 20, 40 and 60 (iM. DMSO (5 ml/ml) served 
as negative control. For metabolic activation 
experiments, liver S9 fraction was freshly prepared as 
per standard procedure[14]. 0.5 ml of S9 mix was 
added along with each treatment after 24 hours of 
the commencement of culture. Negative control was 
also given 0.5 ml of S9 mix. 
Two hours before harvesting, 0.2 ml of 
colchicine (0.2 mg/ml) was added to the culture 
tubes. Cells were centrifliged at 800-1000 rpm for 10 
min. The supernatant was removed and 5 ml of pre-
warmed (37°C) 0.075 M KCl hypotonic solution was 
added. Cells were resuspended and incubated at 37°C 
for 15 min. The supernatant was removed by 
centrifugation and 5 ml of fixative (methanol: glacial 
acetic acid, 3:1) was added. The fixative was 
removed by centrifugation and the procedure was 
repeated twice. The slides were stained in Giemsa 
solution in phosphate buffer for 15 min. At least 300 
metaphases were analyzed for different types of 
chromosome breakage frequencies. Classification of 
aberrations was done according to the guidelines of 
the International Programme on Chemical Safety, 
WHO, Geneva, for the study of genetic defects in 
human population. 
Si.iter chromatid exchange analyses 
For SCE analysis, BrdU (10 mg/ml) was added 
at the beginning of the culture. After 24 hours, same 
treatments were given as for CA analysis. Two hours 
before harvesting, 0.2 ml of colchicine (0.2 mg/ml) 
was added, followed by hypotonic treatment and 
fixation and processing of slides[18] was done as for 
CA analysis. Slides were stained for 20 min in 
0 .05% (w/v) Hoechst 33258 solution, rinsed with tap 
water and placed under a UV lamp for 90 min 
covered with Sorcnsen's buffer (pH 6.8) and stained 
with Giemsa solution in phosphate buffer for 15 min. 
The sister chromatid exchange average was taken 
from an analysis of 50 metaphases. 
Statistical analysis 
Student 's t-test was used for calculating the 
statistical significance in CAs and SCEs. The level of 
significance was tested using standard statistical 
tables[23]. 
Resul ts and discussions 
Results 
The number of abnormal cells with CAs was 
insignificantly low at treatment doses of 1, 10, 20 
mM, respectively, for both steroids being tested for 
genotoxicity, in tiic presence as well as absence of 
metabolic activation i.e. S9 mix (Tables 1 and 2). A 
dramatic increase in genotoxic damage was noticed 
when the dosage was increased to 40 and 60 mM. At 
this dosage level, the abnormal cells more than 
doubled, although the dose-dependent increase in 
CAs was small from 40 to 60 mM. 
SCE frequency in human lymphocytes 
treated separately with stanozolol and trenbolone 
(Tables 3 and 4), again with and without S9 mix, 
followed a pattern similar to the one observed for 
CAs. At 1, 10 and 20 mM, the SCE frequency 
remained quite low and showed little increase. But as 
the dosage increased to 40 mM and then 60 mM, a 
more than three fold increase in SCEs per cell was 
observed. Again, the dose-dependent rise in SCE 
frequency was small going from 40 to 60 mM. 
Discussion 
The use of stanozolol in sports is illegal and 
banned by the International Association of Athletics 
Federations. It has a large oral bioavailability due to 
a C, , alpha-alkylation which allows the hormone to 
survive first pass liver metabolism. High doses of 
stanozolol could exert a proliferative effect on liver 
cells[2]. Acute overdosage can produce nausea and 
gastrointestinal upset. Chronic use of stanozolol can 
cause menstrual irregularities and virilization in 
women and impotence, premature cardiovascular 
disease and prostatic hypertrophy in men. Precocious 
prostatic cancer has been described after long term 
anabolic steroid abuse[20]. Cases where hepatic 
cancers have been associated with anabolic steroid 
abuse have been reported[17]. Also, androgen 
ingestion by a pregnant mother can cause virilization 
of a female fetus[4]. 
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Treatment 
Stunozolol (mfn) 
1 
10 
20 
40 
60 
Untreated 
Negative 
control 
(DMSO, 5 ml/mil 
Positive 
control 
Abnormal eella 
(% ± SE) 
I 00 ± 0 57 
I 33 ± 0 66 
1 67 ± 0 73 
4 00 ± 1 13' 
5 33 ± 1 29" 
0 67 ± 0 47 
1 00 ± 0 57 
1 
8 33 + 1 59' 
CMitomycin r . 0 3 niK/ml) 
2007 
in bum 
Brca 
Gaps 
3 
3 
4 
8 
12 
1 
1 
14 
an l^mphocytcH 
k-up 0 
CTB 
2 
2 
2 
9 
11 
1 
2 
17 
if CAs 
CSB 
1 
2 
2 
3 
5 
1 
1 
12 
CTE 
-
-
-
-
-
-
6 
Die 
-
-
-
-
-
-
2 
(f", 
Treatment 
(wtth S9 mix) 
Stanozolol (mM) 
1 
10 
20 
40 
6 0 
Untreated 
Negative 
control 
Abnormal cells 
(% * SE» 
I 00 ± 0 57 
1 00 ± 0 57 
1 33 i 0 66 
4 33 ± 1 IT 
5 00 ± 1 25° 
0 67 ± 0 47 
1 00 ± 0 57 
(DMSO, 5 mlMil) 
Positive 
control 
0 ^ X 10^ M) 
7 67 ± 1 53" 
Break-i(p o 
Gaps 
1 
2 
2 
9 
10 
1 
1 
12 
C I B 
2 
2 
2 
9 
10 
2 
2 
14 
f CAt 
— 
C S B 
1 
1 
2 
4 
5 
-
1 
6 
41 
CTE Die 
-
-
-
4 2 
'Significant difference with rcipcct to untreated (P<0 05) 
'Signiritant difference with respect to untreated (P<0 01) 
SF Standard Frror 
T « b l c 2 
Treatment 
(without 89 mix) 
Trcnbolonc ( m M ) 
1 
10 
20 
40 
60 
Untreated 
Negative control 
( D M S O , 5 ml/ml) 
Positive control 
(Mitomycin C, 0 3 
Abnormal cclh 
(% + SF) 
0 67 + 0 47 
1 00 * 0 57 
1 33 + 0 66 
3 31 + 1 03' 
4 33 + 1 \T 
0 67 + 0 4 7 
1 00 + 0 57 
9 33 ± I 67* 
liK/ml) 
Break 
. Gaps 
1 
1 
2 
9 
10 
1 
1 
16 
-up of Cas 
C I B 
2 
2 
2 
6 
% 
1 
2 
18 
CSB 
1 
2 
4 
5 
1 
10 
c i t 
-
-
5 
Treatment Abnormal cells 
(with S9 mix) {% ± SE) 
DIC 
Trcnbolonc ( m M ) 
1 0 67 -t 0 47 
10 0 67 ± 0 47 
20 1 00 ± 0 57 
40 3 67 + 1 08" 
60 4 00 ± ) IS ' 
Unueatcd 0 67 ± 0 47 
Negative control 0 67 ± 0 47 
( D M S O , 5 ml/ml) 
1 Positive control 8 00 ± 1 56' 
(CP, 0 5 x 1 0 ' M ) 
Bicak 
Gaps 
2 
2 
2 
8 
9 
2 
15 
:-up o 
CTB 
2 
2 
2 
7 
8 
2 
1 
17 
f CAs 
CSU 
1 
1 
4 
4 
-
1 
CTE 
-
-
-
-
6 
Die 
2 
'Significant difference with respect to untreated (P<0 05) 
'Significant difference with respect to untreated (P<OOI) 
SE Standard Error 
Tnblc 3; SCE frequency in human lymphocytes treated with Stanozolol 
Treatment (without S9 mix) SCEs/Ccll (Mean * SE) Treatment (with S9 mix) SCEs/Ccll (Mean * SE) 
Stanozolol 
I mM 
10 inM 
20 mM 
40 mM 
60 mM 
Untreated 
Negative control 
(i:)MSO, 5ml/ml) 
PoHitive control 
(Mitomycin C, 0 3 v.r./ml) 
2 12 ± 0 18 
2 36 ± 0 22 
2 74 ± 0 24 
6 82 + 0 64" 
7 22 ± 0 66" 
I 24 ± 0 12 
1 1 6 * 0 1 0 
10 22 ± 1 02' 
'SigniTicant difference with respect to untreated (P<0 05) 
"Sigmricant difference with respect to untreated (1'<0 0I) 
SF Standard Error 
Stanozolol 
I mM 
10 mM 
20 mM 
40 mM 
60 mM 
Untreated 
Negative control 
(DMSO, 5ml/ml) 
Positive control 
(CP. 0 5 X 10 ' M) 
2 46 ± 0 20 
2 56 ± 0 22 
2 82 ± 0 26 
6 24 ± 0 62 ' 
7 62 ± 0 68' 
I 28 ± 0 14 
I 22 ± 0 12 
10 86 ± I 12" 
Table 4; SCE frequency in human lymphocytes treated with Trcnbolonc 
Treatment (without S9 mix) 
Trcnbolonc 
SCEs/Cell (Mean * SE) Treatment (with S9 mix) 
1 mM 
10 mM 
20 inM 
40 mM 
60 mM 
Untreated 
Negative control 
(DMSO, 5ml/ml) 
Positive conuol 
(Mitomycm C. 0 3 un/ml) 
2 06 ± 0 14 
2 U ± 0 18 
2 42 ± 0 20 
6 24 ± 0 64" 
6 88 ± 0 66' 
I 02 ± 0 08 
1 96 ± 0 12 
9 96 ± 0 96" 
'Significant difference with respect to 
'Significant difference with respect to 
SL Standard Error 
untreated (P<0 05) 
untreated (P<0 01) 
Trcnbolonc 
1 mM 
10 mM 
20 inM 
40 mM 
60 mM 
Untreated 
Negative control 
(DMSO, 5ml/ml) 
Positive control 
(CP, 0 5 X 10 ' M) 
SCFVCell (Mean ± SE) 
2 02 ± 0 12 
2 10 * 0 14 
2 26 ± 0 18 
6 02 ± 0 60' 
6 88 * 0 66' 
1 98 + 0 14 
1 88 :fe 0 10 
9 72 * 0 92* 
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Trenbolone compounds have a binding affinity 
tor the androgen receptor thrice as hi^h as that of 
testosterone. Once metabolized, the drugs have the 
effect of increasing nitrogen uptake by muscles, 
}eading to an increase in the rate of protein synthesis. 
I'hey also have the secondary effects of stimulating 
appetite, reducing the amount of fat being deposited 
in the body, and decreasing the rate of catabolism. 
Some short term side effects include insomnia, high 
blood pressure and increased aggression and libido. 
However, women suffer virilization effects even at 
small doses[29]. 
The only legitimate therapeutic indications for 
such anabolic steroids are in the replacement of male 
sex steroids in men who have androgen deficiency, 
e.g. due to loss of both testes, in the treatment of 
certain rare forms of aplastic anemia which are or 
may be responsive to anabolic androgens, and in 
certain countries to counteract catabolic states, e.g. 
after major trauma. 
This experiment implies that the synthetic 
anabolic steroids, stanozolol and trenbolone, have 
the potential to cause genotoxic damage in 
human lymphocytes in vitro at higher dosage 
both in the presence and absence of S9 mix. 
Changes in chromosome structure due to a break 
or a swapping of chromosomal material are 
termed as CAs. Most of the CAs in cells are 
lethal, but many of them are also viable and 
can cause genetic effects, either somatic or 
inherited[27]. These events can lead to the loss of 
chromosomal material at mitosis or to the inhibition 
of exact chromosome segregation at anaphase. The 
result of these changes is cell lethality[28]. In our 
experiment, we came across significant differences 
compared with control in the CA frequency at 40 
and 60 mM, with or without S9 mix. SCE is usually 
a more sensitive indicator of genotoxic effects than 
CA[28]. There is a correlation between the 
carcinogenicity and SCE inducing ability of many 
chemicals. Moreover, the SCE induction mechanism 
is heterogeneous and very different from the 
mechanism of CA induction[8]. Androgenic steroids 
display teratogenic effects in all species that have 
been studied so far, and do so in a very predictable 
and consistent way[13]. Various psychological and 
physiological effects have been reported in both 
males and females among frequent users of 
androgens[15]. There is little, if any, information 
available on the exact reasons for the genotoxic 
behavior of stanozolol and trenbolone. However, the 
present study is concurrent with the studies 
performed on synthetic steroids such as cyproterone 
acetate, ethynodiol diacetate, chlormadinone acetate, 
medroxyprogesterone acetate, norgestrel and 
megestrol acetate that induced CAs and SCEs with 
or w i t h o u t m e t a b o l i c a c t i v a t i o n 
system[l,10,21,22,23,25,261. 
Conclu.iion 
The outcome of this investigative experiment 
shows that stanozolol and trenbolone have the 
potential to be genotoxic and cytotoxic, especially at 
40 and 60 mM, with or without metabolic activation, 
in cultured human lymphocytes. 1'he evaluation of 
these genotoxicity tests is a usefiil tool for 
determining the toxic effects of potentially genotoxic 
chemicals, leading to identification of such 
carcinogenic agents. It is advisable to use the steroids 
studied here at their lowest effective dosage so that 
the risk to public health could be minimized. The 
risk of damage to human genetic material is very 
likely at higher doses of these drugs. 
Acknowledgement 
We gratefiilly acknowledge the indispensable 
laboratory facilities provided by the Chairman, 
Department of Zoology, AMU, for this experiment to 
be successfiilly conducted. 
References 
1. Ahmad, M.E., G.G.H.A. Shadab, M.A. Azfer and 
M. Afzal, 2001. Evaluation of Genotoxic 
Potential of Synthetic Progestins - Norethindrone 
and Norgestrel in Human Lymphocytes In yUro. 
Mutation Research, 494: 13-20. 
2. Boada, L.D., M. Zumbado, S. Torres, A. Lopez, 
B.N. Diaz-Chico, J.J. Cabrera and O.P. Luzardo, 
1999. Evaluation of Acute and Chronic 
Hepatotoxic Effects Exerted by Anabolic-
Androgenic Steroid Stanozolol in Adult Male 
Rats. Archives of Toxicology, 73(8-9): 465-472. 
3. Carballo, M.A., S. Aluarez and A. Boveris, 1993. 
Cellular Stress by Light and Rose Bengal in 
Human Lymphocytes. Mutation Research, 288: 
215-222. 
4. Dewhurst, 1. and R.R. Gordon, 1984. Fertility 
Following Change of Sex: a Follow-up. Lancet, 
22; 2(8417-8418): 1461-1462. 
5. Elashoff, J.D., A.D. Jacknow, S.G. Shain and 
G.D. Braunstein, 1991. Effects of Anabolic-
Androgenic Steroids on Muscular Strength. 
Annals of Internal Medicine, 115(5): 387-393. 
6. Fisher, R.A. and Y. Yates, 1963. Statistical Table 
for Biological, Agricultural and Medical 
Research, 6"* edition. Oliver and Boyd, 
Edinburgh. 
7. Gannon, T., 1994. Dermatologic Emergencies. 
When Early Recognition can be Lifesaving. 
Postgrad Medicine, 96(5): 28-30. 
8. Gebhart, E., 1981. Sister Chromatid Exchange 
(SCE) and Structural Chromosome Aberrations 
in Mutagenicity Testing. Human Genetics, 
58: 235-254. 
Adv Environ Biol, 1(1) 39-43. 2007 43 
9 Haynes, R C Jr and F Murad, 1985 
Adrenocorticotropic hormone. Adrenocortical 
steroids and their synthetic analogs. Inhibitors of 
adrenocortical steroid biosynthesis In The 
pharmacological basis of therapeutics, E d s , 
Oilman, A G , L S Goodman, T W Rail and F 
Murad New York Macmillan Publishing Co , 
pp 1459-1489 
JO Hundal, B S , V S Dhillon and I S Sldhu, 1997 
Genotoxic Potentials of Estrogens Mutation 
Research, 389 173-181 
11 International Programme on Chemical Safety, 
1985 Environmental Health Criteria 46 
Guidelines for the study of genetic effects in 
human population WHO, Geneva, 25-54 
12 International Programme on Chemical Safety, 
1993 Poisons Information Monograph 918, 
Pharmaceutical WHO, Geneva PIM G007 
13 Juchau, M R , 1997 Chemicals recognized as 
teratogenic in humans in Progress in drug 
research. Vol 49, E d s , Juckcr, E Boston 
Birkhauser Verlag, pp 25 92 
14 Maron, D M and B N Ames, 1983 Revised 
Methods for the Salmonella Mutagenicity Test 
Mutation Research, 113 173-215 
15 McEvoy, G K , 1995 Al lFS 95 drug 
information American Society ot Health System 
Pharmacists, Bethesda, MD , pp 2128 
16 Mooradian, A D , J E Morley and S G 
Korenman, 1987 Biological Actions of 
Androgens Endocrine Reviews, 8(1) 1-28 
17 Overly, W L , J A DankofF, BK. Wang and 
U D Smgh, 1984 Androgens and Hepatocellular 
Carcmoma in an Athlete Annals of Internal 
Medicine, 100(1) 158 159 
18 Perry, P and S Wolff, 1974 New Giemsa 
Method for Differential Staining of Sister 
Chromatids Nature, 251 156-158 
19 Richold, M , 1988 The Genotoxicity of 
frenbolone, a Synthetic Steroid Archives of 
Toxicology, 61(4) 249-258 
20 Roberts, J T and D M Essenhigh, 1986 
Adenocarcinoma of Prostate in a 40 year old 
Body builder Lancet, 2 742 
21 Siddique, Y H and M Afzal, 2004" Evaluation 
of Genotoxic Potential of Synthetic Progestin 
Chlormadmone Acetate Toxicology Letters 
153 221-225 
22 Siddique, Y H and M Afzal, 2004" Evaluation 
of Genotoxic Potential of Ethynodiol Diacetate in 
Human Lymphocytes In Vitro Current Science, 
86 1161-1165 
23 Siddique, Y H and M Afzal, 2004= Induction of 
Chromosomal Aberrations and Sister Chromatid 
Exchanges by Cyproterone Acetate in Human 
Lymphocytes International Journal of Human 
Genetics, 4(3) 187-191 
24 Siddique, Y H , G Ara, T Beg and M Afzal, 
2 0 0 6 G e n o t o x i c P o t e n t i a l o f 
Medroxyprogesterone Acetate m Cultured Human 
Peripheral Blood Lymphocytes Life Sciences, 
80 212 218 
25 Siddique, Y H , T Beg and M Afzal, 2005* 
Genotoxic Potential of Ethinylestradiol in 
Cultured Mammalian Cells Chemico-Biological 
Interactions, 151 141-144 
26 Siddique, Y H , T Beg and M Afeal, 2005" 
Antigenotoxic Effects of Ascorbic Acid Against 
Megestrol Acetate Induced Genotoxicity in 
Mice Human and Experimental Toxicology, 
24 121 127 
27 Swierenga, S H H , J A Heddle, E A Sigal, 
J P W Gilman, R L Brillmger, G R Douglas 
and E R Nestmann, 1991 Recommended 
Protocols Based on a Survey of Current Practice 
m Genotoxicity Testing Laboratories, IV 
Chromosome Aberration and Sister Chromatid 
Exchange in Chmese Hamster Ovary V79, 
Chmese Hamster Lung and Human Lymphocytes 
Cultures Mutation Research, 246 301 322 
28 lucker, J D and R J Preston, 1996 
C h r o m o s o m e Aberra t ions , M i c r o n u c l e i , 
Ancuploidy, Sister Chromatid Exchanges and 
Cancer Risk Assessment Mutation Research, 
365 147-159 
29 Wikipedia, 2007 The Free Encyclopedia 
http //en wikipedia org/wiki/Trenbolone 
Antigenotoxic Potential of Gingerol 
in Cultured Mammalian Cells'^  
Tanveer Beg*, Yasir Hasan SIddlQue** and Mohammad Afzal*** 
6-Glngerol, a naturaljy occurring plant phenol, is one of the major phannacologically 
active components of fresh ginger {Zingiber offidnald^. In the present study, we have 
tested 5. 10. and 20 //M of gingerol against 60 /M of Methyl Methanesulphonate 
(MMS) induced genotoxic damage in the presence as well as absence of metabolic 
activation system (S9 mix). The experiments were performed using Sister Chromatid 
Exchanges (SCEs) and Chromosomal Aberrations (CAs) as parameters in cultured human 
lymphocytes. Gingerol was found to reduce the genotoxic damage both in the presence 
as well as absence of S9 mix for all the tested doses. The results of the present study 
show that gingerol could reduce the genotoxic damage induced hy methyl 
methanesulphonate. 
Keywords: Gingerol. Anligcnoloxicity. Methyl metiianesulphonate. 
Introduction 
Ginger {Zingiber officinale. Roscoe, Zingiberaceae) is a Southern Asian plant cultivated in 
the tropics. The root of ginger called rhizome is used for culinary and medicinal purposes 
(Huang et al.. 1990). It has carminative, diaphoretic and antispasmodic properties. 
Its intake reduces clotting, cholesterol and blood pressure. It is anti-inflammatory, and 
helpful in controlling nausea, and has tonic effect in digestion. Extracts of groups have 
antioxidant activity through scavenging of superoxide and hydroxyl radicals and by inhibiting 
lipid peroxidation (lOkuzaki and Nakatani, 1993). It is antibacterial and antifungal and is used 
for common cold (Bode et al.. 2001). 
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The key constituents of ginger include volatile oils (bisabolene. cineol. phellandrene. citral. 
borneol. citronellol, geranial. linalool. Ilmonene. zlngibcrol and camphene). oleoresin (gingerol 
and slogaol). phenol (glngeol and zingerone). proteolytic enzyme (zingibain), vitamin B6, 
vitamin C, Ca. Mg. R K and linoleic acid. The pungency of ginger is due to gingerol. an 
alcohol of oleoresin. The aroma is due to oil (Hasenohrl et ai. 1998). 
6-Gingerol \s the major pharmacologically active component inducing apoptosis (Lee and 
Surh. 1998: and Lee et ai. I ^ ^^) in cancer cells. Although it reveals mutagenic activity 
in 5a//770/7e//4^Microsome assay (Nagabhushan et ai. 1987). its antioxidant activity has not 
been studied. The present work is an attempt to see the same in in vitro human lymphocyte 
assay. 
Materials and Methods 
Chemicals: 6-Gingerol (9896) was procured from Bio Mol Research Laboratories Inc. 
(Plymouth Meeting. PA) in powder from RPMI-1640 Medium. Foetal calf serum, 
phytohaemagglutinin was procured from Gibco. colchicine 0.02 /Jg/ml (Microlab). Hoeschst 
332S8 stain (0.05% w/v) (Sigma). 3% Giemsa solution in phosphate buffer (pH 6.8) 
(E Merck India). 5-Bromo-2-deoxyuridine 10 /ig/ml (BrdU. Sigma). Methyl Methanesulphonate 
(MMS) from SRL (India). 
lymphocyte Culture: Duplicate peripheral blood cultures were prepared according to 
Carballo et al. (1993). Briefly. 0.5 ml of heparinized blood samples were obtained from two 
healthy male donors with no recent history of exposure to mutagens and were placed in a 
sterile tube containing 7 ml of RPMI medium supplemented with 1.5 ml foetal calf serum 
and 0.1 ml of phytohacmagglutinin. MMS was added to the culture at 60 fM concentration 
(treatment) to induce clastogen. In another three cultures of blood, medium and 60 /jmM. 
of MMS each, 6-Gingcrol solution was added in 5. 10 and 20 / iM each; while in yet another 
culture gingerol was added only as 5. 10 and 20 /M. The fourth set was untreated culture 
(control). All these additions were done 24 h after the plantation of culture. The cultures 
were placed In incubator at 37 °C with 5% COj. Harvesting was done with colchicine, and 
metaphase slides were prepared and stained as usual for clastogeny. Slides were scored blind 
for breakage gaps and dicentrics, and 300 metaphases were scored. 
Sister Chromatid Exchange (SCE): For SCE. another set of experiments were conducted 
with the same treatments. BrdU (10 //g/ml) was added to all cultures in darkness and Hoeschst 
and Giemsa staining was done as usual for dilTerential staining of chromatids. Exchanges were 
scored and SCE level was counted in all treatments and control. 50 metaphases were scanned 
for each treatment and control based on Perry and Wolff (1974). 
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Statistical Analysis: The results were evaluated statistically with two-tailed students' T 
test and significance level was ascertained using the tables of Rsher apd Yates (1963, p. 138). 
S9 Mix: S9 mix was prepared as per the method of Maron and Ames (1983). The 
experiments were conducted without and with S9 mix treatment for all the parameters. 
Results and Discussion 
The chromosomal aberrations were counted as gaps, chromatid breaks, chromosomal breaks, 
chromatid exchanges and dicentrics. In the absence of S9 mix (Tables I and 2). there is a 
distinct increase in total breaks due to MIVIS (0.67% in control to 3396). However, the breaks 
get reduced from 19% to 7% with addition of increasing concentrations of gingerol. GIngerol 
alone also has lower values of breaks 0.66-1.67% in increasing concentrations, slightly more 
than the control. In the presence of 59 mix (Tables 3 and 4). the breaks are slightjy Increased 
and the control remains the same. With MMS. and with gingerol and MMS. the level Is lower, 
meaning lower action of the mutagen. 
Tabic 1 Effect of Gingerol on Chromosomal Aberrations (CAs) 
Induced by Methyl Methanesulphonate In the Absence of S9 MU 
MMS (A/M) 60 
MMS (/A1) 
Qngerol CuM) 
60+S 
60+10 
60+20 
GIngerol (^M) 
5 
10 
20 
Untreated 
Abnormal Metaphases 
without Gaps 
Number 
80 
40 
31 
23 
2 
4 
5 
2 
Mean % 
± SE 
26.67 ±2.55' 
13.33 ± 1.96" 
10.33 ± 1.73"" 
7.67 ± 1.53* 
0.67 ±0.47 
1.33 ±0.66 
1.67 ±0.73 
0.67 ±0.47 
Chromosomal Aberrations 
Gaps 
41 
29 
22 
IS 
1 
2 
2 
1 
CTB 
46 
30 
18 
14 
2 
2 
3 
2 
CSB 
35 
20 
12 
9 
-
2 
2 
-
CTE 
6 
3 
1 
-
-
-
-
-
D l C / 
3 
1 
-
-
-
-
-
-
Total Breaks 
without Gaps 
99 (33.00) 
58 (19.33) 
32 (10.67) 
23 (7.67) 
2 (0.66) 
4 (1.33) 
S (1.67) 
2 (0.67) 
Note:'Slgnincanl with respect to untreated alone (/> < 0.01): •• Signlllcant with respect to MMS (A* < 0.01). 
CTB: Chromatid Break: CSB: Chromosome Break: CTE: Chromatid Exchange: DlC: Dicentric; 
MMS: Methyl Methanesulphonate. 
-
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Table 2: Effect of Gingcrol on Sister Chromatid Exchange 
Induced by Methyl Methanesulphonate In the Absence of 
Treatment 
MMS Uivt) 60 
MMS (MM) + GIngcrol (/zM) 
60+5 
60+10 
60+20 
Gingerol (/<M) 
S 
iO 
20 
Untreated 
MeUphase Scanned 
50 
50 
50 
SO 
50 
SO 
50 • 
SO 
Note:' Sl^inant with respect to untreated alone {P < 0.01): ^ Signlllca 
MMS: Methyl Methanesulphonate; SE: Standard Error. 
SCEs/Cell ± SE 
16.86 + l.ll* 
7.83 ± 0.75" 
6.94 ± 0.68" 
5.04 ± 0.53" 
2.43 ± 0.41 
2.95 ± 0.45 
3.20 ± 0.47 
1.90 ± 0.22 
nt with respect to MMS (P < 
s (SCEs) 
S9 Mix 
Range 
2-18 
1-8 
1-8 
0-6 
OS 
0-5 
0-5 
0-5 
0.01). 
Tabic 3: Effect of Glngerol on Chromosomal Aberrations (CAs) 
Induced by Methyl Methanesulphonate In the Presence of S9 Mix 
Treatment 
MMS CMM) 60 
MMS (//M) + 
Gingcrol OuM) 
60+5 
60+10 
60+20 
Glngcrol (/M) 
5 
10 
20 
Untreated 
Note:'Sicilian 
CTB: Chrc 
MMS: Me 
Abnormal Metaphases 
without Gaps 
Number 
86 
30 
2! 
r6 
3 
3 
4 
3 
t with respec 
matid Break 
Ih^ Metham 
Mean % 
± SE 
28.67 ± 2 . 6 1 ' 
10.00 ± 1.73" 
7.00 ± 1.47" 
5.33 ± J.29" 
1.00 ± 0 . 5 7 
1.00 ±0 .57 
1.33 ±0 .66 
1.00 ± 0 . 5 7 
Chromosomal Aberrations 
Gaps 
47 
21 
13 
9 
2 
2 
2 
1 
CTB 
48 
22 
IS 
12 
2 
2 
2 
2 
CSB 
40 
8 
6 
4 
1 
1 
2 
1 
CTE 
7 
-
-
-
D i e 
4 
-
-
-
Total Breaks 
without Gaps 
110 (36.67) 
30(10.00) 
21 (7.00) 
16 (5.33) 
3 (1.00) 
3 (1.00) 
4 (1.33) 
3 (1.00) 
1 to untreated alone {P < 0.01):" Significant with respect to MMS {P < 0.01). 
CSS: Chronrosome Break: CTE: Chromatid Exchange: DIG: Dicentric: 
»ulphonale. 
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Table 4: Effect of GIngerol on Sister Chromatid Exchanges (SCEs) 
Induced by Methyl Methanesulphonate In the Presence of S9 Mix 
Treatment 
MMS (/iM) 60 
MMS OuM) + Gingcrol (fM) 
60+S 
60+10 
60+20 
Gingcrol {pM) 
S 
10 
20 
Untreated 
Mctaphasc Scanned 
50 
50 
50 
SO 
50 
50 
50 
50 
SCEs/Ccll ± SE 
17.83 ± 1.23* 
8.21 ± 0.84" 
7.01 ± 0.73'" 
6.24 ± 0.62* 
2.02 ± 0.31 
2.31 ± 0 . 3 6 
2.45 ± 0.39 
1.83 ± 0.20 
Range 
2-18 
2-9 
1-8 
1-7 
0-5 
0-5 
0-5 
0-5 
Note: • Signlfianl wilh respect to untreated alone {P < O.Ol); * Slgnlflant with respect to MMS {P < 0.01). 
MMS: Methyl Methanesulphonate; SI: Standard Error. 
Sister Chromatid Exchange: The level of SCE is Increased due to the presence of MMS 
(1796 from 2% in control); the effect of MMS gets reduced with the use of glngerol, from 
7.896 to 596; with gingerol alone the values are lower from 296 to 396 (Table 2). In the presence 
of S9 mix, the results follow the same trend; again the effect Is more pronounced as compared 
to that without S9 mix (Table 4). 
Conclusloti 
Lee et al. (1986) studied the antioxidant activity of ginger. Cao et al. (1993) reported the 
scavenging effects of ginger on superoxide anion, and hydroxyl radical 6-glngerors activity 
may be to scavenge O^  as has been reported in h^oxanthlne oxidase system and OH in 
UV exposure to H^Oj system. The scavenging effect on O^  and OH' may contribute to 
explaining the pharmacological action of 6-gingerol (Lee et al., 1998) and determining the 
antitumor promotional activity of 6-gingerol. the major pungent principle of ginger, using 
a two-stage mouse skin carcinogenesis model. Application of 6-glngerol onto shaven backs 
of female ICR mice prior to each topical dose of 12-0-TetradecanqyI Phorbor-I3-Acetate 
(TPA). significantly Inhibited 7. 12 dimethyl benz la| anthracene-Induced skin 
papillomaganesis. The compound also suppressed TPA-induced epidermal ornithine 
decarboxylase activity and inflammation. The antioxidant activity of 6-gingerol may further 
be studied with other assay systems. Q 
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